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A B S T R A C T
Background
In primary care between 10% and 35% of all visits concern patients with medically unexplained physical symptoms (MUPS). MUPS
are associated with high medical consumption, significant disabilities and psychiatric morbidity.
Objectives
To assess the effectiveness of consultation letters (CLs) to assist primary care physicians or occupational health physicians in the treatment
of patients with MUPS and diagnostic subgroups.
Search methods
We searched for randomized controlled trials (RCTs) on the Cochrane Collaboration Depression, Anxiety and Neurosis Group Con-
trolled Trials Registers, the Cochrane Central Register of Controlled Trials (CENTRAL, Issue 2, 2009), MEDLINE (1966-2009),
MEDLINE In Process (2009-08-17), EMBASE (1974-2009), PSYCINFO (1980-2009) and CINAHL (1982-2009). We screened the
references lists of selected studies and consulted experts in the field to identify any additional, eligible RCTs.
Selection criteria
RCTs of CLs for patients with MUPS being treated in primary care settings.
Data collection and analysis
Two authors independently screened the abstracts of the studies identified through the searches and independently assessed the risk of
bias of the included studies. We resolved any disagreement by discussion with a third review author. We assessed heterogeneity and,
where a number of studies reported the same outcomes, pooled results in a meta-analysis.
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Main results
We included six RCTs, with a total of 449 patients. In four studies (267 patients) the CL intervention resulted in reduced medical
costs (in two studies the outcomes could be pooled: MD -352.55 US Dollars (95% CI -522.32 to -182.78)) and improved physical
functioning (three studies, MD 5.71 (95%CI 4.11 to 7.31)). In two studies (182 patients) the intervention was a joint consultation with
a psychiatrist in presence of the physician, and resulted in reduced severity of somatization symptoms, reduced medical consumption
and improved social functioning.
Authors’ conclusions
There is limited evidence that a CL is effective in terms of medical costs and improvement of physical functioning for patients with
MUPS in primary care. The results are even less pronounced in patients with clinically less severe, but more meaningful, forms of
MUPS and the results vary for other patient-related outcomes. All studies, except one, were performed in the United States and therefore
the results can not be generalized directly to countries with other healthcare systems. Furthermore all studies were small and of only
moderate quality. There is very limited evidence that a joint consultation with the patient by a psychiatrist in the presence of the
physician, together with the provision of a CL, reduces severity of somatization symptoms and medical consumption.
P L A I N L A N G U A G E S U M M A R Y
Consultation letters for use by primary care physicians in their care of patients with physical symptoms for which no organic
cause can be found
In 10% to 35% of all consultations in primary care, no organic cause can be found for the physical symptoms of the patient. Patients
may present with symptoms such as fatigue, headaches, dizziness, non-specific low back pain and chest pain. Such symptoms can lead
to frequent consultations with the physician and high medical costs as well as causing considerable worry and disability for the patient.
Patients suffering from MUPS are more likely than the average patient to experience depressive and anxiety disorders. Studies have
reported positive effects of screening by a psychiatrist in the treatment of MUPS in primary care. After screening, the psychiatrist sends
the primary care physician a ’consultation letter’ (CL) which states the diagnosis and that patients are best helped by: 1) having their
symptoms taken seriously; 2) not being told their symptoms are ’all in your head’; 3) not being referred for further investigation unless
there is a clear indication of a somatic disorder; 4) undergoing a physical examination at each visit; and 5) being seen at regular intervals.
In our review we found six studies, with a total of 449 patients, in which one of two interventions were applied. One intervention
(four studies, 267 patients) was a CL following a consultation between the patient and the psychiatrist; the other (two studies, 182
patients) was a CL following a joint consultation between patient, psychiatrist and primary care physician. In each case comparison was
against care as usual, provided by the primary care physician. The first intervention resulted in reduced medical costs (three studies)
and improved physical functioning (three studies). We found evidence for a slight reduction in the severity of the MUPS, reduced
medical consumption and improved social functioning following the second intervention, although in only one of two studies assessed.
There are serious limitations in generalizability of the results to modern healthcare: most trials reported doctor-related outcomes with
patient-related outcomes varying in results; the intervention appears to be far more effective for the most serious but rare disorders,
and less so in the more common forms of MUPS; five of the six studies were performed in the United States and four studies before
1995. Furthermore the studied populations were small and five of the six studies were of moderate quality.
Our final conclusion is that CLs may be helpful for physicians who treat patients with MUPS (based on the provider-related outcomes).
However, until further studies are conducted to find out if the intervention results in improved patient-related outcomes, the overall
effectiveness of CLs cannot be demonstrated.
B A C K G R O U N D
Description of the condition
In general practice, 10% to 35% of all consultations (Bridges
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1985; Escobar 1987; De Waal 2004) concern patients with med-
ically unexplained symptoms. These patients present with phys-
ical symptoms such as fatigue, non-specific headache and non-
cardiac chest pain (NCCP), for which no organic cause can be
found. These symptoms are commonly described as medically un-
explained physical symptoms (MUPS) (Burton 2003). If the pa-
tient attributes the symptoms to an organic cause and seeks medi-
cal help, this process is described as ’somatization’; however,MUPS
is a more objective term, which is more frequently used in recent
scientific literature and is more in accordance with use in primary
care (Burton 2003).
There is a continuum from incidental and short-lasting MUPS,
to persisting and recurrent MUPS, to a life-long history with at
least 13 MUPS, which is categorized as somatization disorder ac-
cording to DSM IV (APA 1994). Somatization disorder is one
of the most serious and rare somatoform disorders, which is an
important group of disorders in DSM IV. Other examples of so-
matoform disorders are conversion, body dismorphic disorder and
hypochondriasis, but these disorders are outside the scope of this
review. In the continuum of severity of MUPS referred to above,
the forms with more symptoms and longer lasting symptoms are
associated with higher levels of disability and psychiatric comor-
bidity (e.g. depression and anxiety), decline in subjective health,
increased healthcare utilization and a corresponding increase in
costs (Bridges 1985; Escobar 1987; Craig 1993; Escobar 1998).
There are several somatoformdiagnostic subgroups which are used
in many studies, especially abridged somatization disorder (ASD)
and multisomatoform disorder (MSD). These are subthreshold
forms of somatization disorder. For the diagnosis of ASD a lifetime
history of four (men) to six (women) MUPS according to DSM
criteria is needed (Escobar 1998), while for the diagnosis of MSD
a patient needs to be affected by three currentMUPS, along with a
history of MUPS of at least two years (Kroenke 1997). The preva-
lence rates of somatization disorder, ASD and MSD differ widely
with percentages of 1% to 4%, 20% and 8% in general practice
populations (Gureje 1997). Because of their high prevalence, ASD
andMSD are clinically most meaningful to primary care. As sever-
ity, count of symptoms and prevalence rates vary so widely, there
should be caution in comparing, especially somatization disorder
with ASD and MSD. Of the patients with five or more current
MUPS, 50%meet the criteria for another psychiatric disorder (e.g.
depression or anxiety) and 63% report psychological symptoms
(Simon 1991). In 50% of cases, this psychiatric comorbidity is not
recognized by the primary care physician (Bridges 1985). Primary
care physicians describe patients withMUPS as difficult and time-
consuming (Schilte 2000) and MUPS are also associated with a
more difficult doctor-patient relationship, because the doctor and
the patient hold different opinions about the causes and treatment
of MUPS (Hahn 2001). Therefore, there is a need to improve
adequate diagnosis and treatment of patients with MUPS. Since
MUPS are associated with great reduction in subjective health and
increased healthcare utilization, many studies have one or both
types of these outcomes as a primary outcome.
MUPS are also common in the occupational health setting. In
many countries occupational health care is part of, or related to,
primary care with regard to the counselling of employees who are
on sick leave. MUPS are responsible for a considerable amount
of long-term sick leave, due to disorders such as chronic fatigue
syndrome, NCCP and fibromyalgia. These disorders are associ-
ated with delayed recovery, prolonged sick leave and disabilities
(Eriksen 1998; Furze 2001). In most of these disorders the medi-
cal condition alone does not explain the severity of the disabilities
and the duration of the sick leave (Peski 1999; Norrmén 2008).
Sickness absence, in general, is associated with reduced well-being,
a heavy socio-economic burden, and high costs (Marmot 1995).
A correlation with dysfunctional health beliefs has been demon-
strated, and interventions focusing on these beliefs are effective in
hastening return to work (Van Tulder 2000; Petrie 2002).
Description of the intervention
Primary care physicians need effective therapeutic strategies for
the treatment of MUPS (Kerwick 1997). Cognitive behavioural
therapy (CBT) provided by a psychologist has been shown to be
effective (Kroenke 2000), but patients with MUPS often refuse
psychological or psychiatric referral for treatment. A Cochrane re-
view showed limited evidence of effectiveness for cognitive inter-
ventions provided by general practitioners for patients withMUPS
(Huibers 2003).
An alternative intervention is the consultation letter (CL). This
was used for the first time in a standardized way by Smith (Smith
1986a), and later by other investigators (Rost 1994; Smith 1995;
Dickinson 2003). In these studies, primary care patients were
screened for multiple and recurrent MUPS by means of validated
questionnaires and a structured psychiatric interview carried out
by a research psychiatrist. If the diagnosis ofmultiple and recurrent
MUPS (in a severe or less severe form, depending on the study cri-
teria for the investigation) was confirmed, a standardized detailed
CL was sent to the patient’s primary care physician. Although the
CL is sent to the primary care physician, it is often referred to in
studies as a patient consultation letter, and this may be confusing,
because the letter is not usually sent to the patient. Sometimes the
letter is referred to as a ’care recommendation letter’ (Dickinson
2003a), but in this review we will refer to them as CLs.
How the intervention might work
The chronic relapsing course of the disorder and its low mortality
and somatic morbidity rates are described within the CL. It also
contains detailed recommendations concerning management, i.e.
to avoid diagnostic procedures and hospitalization, to see these
patients at regular intervals and to perform a physical examination
at each visit. There are three components that may contribute to
3Consultation letters for medically unexplained physical symptoms in primary care (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
the effect of the intervention and that can explain how the inter-
vention might work: confirmation of the diagnosis of persistent
MUPS, management rules for communication and management
rules for case management. Which component is the most effec-
tive, or if there is a synergetic effect is not known. In several stud-
ies (Smith 1986a; Rost 1994; Smith 1995; Dickinson 2003), this
CL intervention has resulted in improved health outcomes. It is
assumed that labelling symptoms as MUPS reduces the clinical
uncertainty of the primary care physician and prevents potentially
harmful invasive examinations and (somatic) referrals (Dickinson
2003). CLs might be an efficient method, in terms of time-sav-
ing and cost-effectiveness, for use in primary care to improve the
health and well-being of patients with MUPS.
The intervention, based on the combination of screening and a
CL, can be placed in the model of collaborative care, where the
primary care patient is seen by a psychiatrist. The consultation
is patient-centred. The primary care physician remains the re-
sponsible care-giver, but receives advice about diagnosis and treat-
ment from the psychiatrist. This model has been reported to have
favourable effects on the treatment provided by the primary care
physician and on improving outcomes in patients with depression
(Von Korff 1995). Collaborative care is recommended for compli-
cated and persistentMUPS according to the review ofHenningsen
(Henningsen 2007), although the effects have yet to be evaluated.
This intervention might overcome the reluctance of patients to
psychiatric referral. This is because it has the advantage that the
patient is only referred for one consultation for advice on diagnosis
and treatment. There is no treatment by the psychiatrist, and the
primary care physician continues as the treating physician.
Why it is important to do this review
A systematic review with regard to the intervention with patient
CLs is required to assist and improve the management of patients
with MUPS in primary care. Such a review has yet not been per-
formed. Earlier systematic reviews were focused on the treatment
by a psychologist, multidisciplinary treatment or pharmacologi-
cal treatment and on patients with specific somatoform disorders
(e.g. somatisation disorder, hypochondriasis) and certain func-
tional disorders (e.g. chronic fatigue disorder, fibromyalgia). Fur-
thermore, the studies included in these reviews were often centred
on patients in secondary or tertiary care, limiting the generaliz-
ability to use in primary care.
O B J E C T I V E S
1. To assess the effectiveness of psychiatric consultation letters
compared to treatment as usual for patients with MUPS in terms
of symptom reduction (patient-related outcome).
2. To assess the cost-effectiveness of psychiatric consultation letters
compared to treatment as usual for patients with MUPS (health-
care provider-related outcome).
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials (RCTs) concerning CLs for patients
with MUPS being cared for in primary care.
We considered RCTs that randomized individual patients as well
as studies that randomized clusters of patients at physician or prac-
tice level eligible for inclusion in this study. Cross-over trials were
eligible for inclusion, but we took data only from the first period.
We excluded data from the second period, after cross-over, because
of the risk of carry-over effects.
Quasi-randomized controlled trials were not eligible for inclusion.
Types of participants
Participants must be receiving treatment in a primary care setting
and have a diagnosis of multiple and recurrent MUPS, which is
here defined as the presence of recent (in the past two weeks)
unexplained physical symptoms, together with at least a six-month
history of MUPS, and with at least three unexplained physical
symptoms during the past year.
Unexplainedphysical symptomswere assessedwith validated ques-
tionnaires, such as the SCL-90 somatization subscale (Derogatis
1977), or schedules used in a psychiatric interview, e.g. the Diag-
nostic Interview Schedule (DIS), which is based on the symptoms
listed in the DSM-III-R (APA 1987), DSM-IV (APA 1994) or
DSM-IV-TR (APA 2000).
We excluded studies if the participants were patients in a secondary
and/or tertiary care setting (e.g. the medical specialist or psychi-
atrist is the main care-giver/ the study population is from a sec-
ondary or tertiary healthcare setting).
If the main care was provided in primary care, but the patient
received additional specific care in a secondary or tertiary care
setting for specific medically explained physical symptoms, these
participants were eligible for inclusion.
We excluded studies if participants were children (under 18 years
of age), because the prevalence of MUPS is different in children.
Furthermore, the presentation of the symptoms is also determined
by the parents, and various characteristics and results can not be
generalized to adult patients (Postilnik 2006).
4Consultation letters for medically unexplained physical symptoms in primary care (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Types of interventions
The intervention must consist of a CL written by a psychiatrist
and sent to a primary care physician (general practitioner or occu-
pational health physician), concerning a patient with MUPS, in a
physical one-to-one setting (between patient and physician) after
screening with validated questionnaires and/or structured inter-
views carried out by a research assistant or a psychiatrist. The key
components of the CL should be:
1. an explanation of MUPS and somatization, a description of
its low mortality rate;
2. recommendations for the care of the patient;
3. recommendations for the communication with the patient.
At the very least theCL should include diagnosis (1) and either rec-
ommendations for the care of or communication with the patient
(2 or 3). TheCLcould be a standard letter for patientswithMUPS,
or a patient-related document with recommendations with regard
to the diagnosis of MUPS and specific recommendations within
the context of this specific patient.
The advice of the psychiatrist had to be applied in a primary care
setting by the primary care physician. This advice could be given
in several ways, but it had at least to be written advice which
was sent to the primary care physician. The advice could also
be a combination of written advice and oral advice, or written
advice and advice by telephone from the psychiatrist after the
consultation.
We excluded studies if:
1. the treatment was not provided by the primary care
physician in a face-to-face setting (e.g. group setting, by
telephone, guided self-help intervention, Internet programme);
2. the treatment was provided by other disciplines (nurse,
psychologist) in primary care and the results were not presented
to every discipline (in such cases the role of the primary care
physician was not clear);
3. there was no consultation setting with the primary care
physician being the treating physician, e.g. the psychiatrist
performed part or most of the treatment;
4. the patient was not seen by the psychiatrist (e.g. a
consultee-centred consultation in which the patient was not seen
by the psychiatrist and only the primary care physician was
counselled by the psychiatrist);
5. there was no written advice from the psychiatrist (e.g. only
oral advice or advice by telephone after the consultation);
6. the CL was used in both the intervention and the control
group (as this would prevent assessment of the ’isolated’ effects of
the CL).
Types of outcome measures
Primary outcomes
We assessed the following primary outcome measures:
Health care (provider) -related
1. Use of healthcare resources/medical consumption: number
of hospital days, number of medical visits, medication
prescribed, etc (continuous outcome)
2. Costs of medical consumption (continuous outcome)
Patient-related
1. Severity of MUPS and somatization symptoms assessed
with validated instruments such as the SCL-90 (continuous
outcome) (Derogatis 1977), or during a psychiatric interview
(e.g. DIS) (dichotomous outcomes).
Secondary outcomes
We assessed the following secondary patient-related outcome
measures.
1. Sick leave and return to work: number of sick days and days
until resumption of work (continuous outcome)
2. Functional status: physical, emotional and social
functioning, measured with validated instruments such as sub-
scales of the SF-36 (continuous outcome) (Ware 1993)
3. Perceived health: health perceptions and general health
(continuous outcome)
4. Depression and anxiety measures, derived from a psychiatric
interview (e.g. DIS) or validated questionnaires such as the Beck
Depression Inventory (continuous outcome) (Beck 1987).
Search methods for identification of studies
Electronic searches
Searches were performed for randomized controlled trials (RCTs)
on 17 August 2009 in the Cochrane Collaboration Depression
Anxiety and Neurosis Group Controlled Trials Registers (CC-
DANCTR References and CCDANCTR Studies), the Cochrane
Central Register of Controlled Trials (CENTRAL, Issue 2, 2009),
MEDLINE, (1966-2009), MEDLINE In Process (2009-08-17),
EMBASE (1974-2009), PsycINFO (1980-2009) and CINAHL
(1982-2009). We retrieved all articles that cited relevant studies.
There were no language restrictions.
Identification of search terms
For Medically Unexplained Physical Symtoms (MUPS) we took
the search terms used by Olde Hartman 2009 in their systematic
review on medically unexplained symptoms (MUS), somatization
disorder and hypochondriasis, together with the top 10 functional
syndromes (identified at this point in time) by Henningsen 2007.
We identified additional search terms in collaboration with CC-
DAN’s Trials Search Co-ordinator.
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For the study design we used highly sensitive RCT filters adapted
from (Robinson 2002) and the Cochrane Handbook for Systematic
Reviews of Interventions (Lefebvre 2008).
For the intervention we used terms relating to psychiatric and
specialist consultation, liaison, referral, collaborative intervention,
consultation letters, interdisciplinary and multidisciplinary com-
munication and case management.
The main search strategy was not limited to treatment setting, but
a complementary search for ’consultation-liaison psychiatry’ was
limited to primary care practice using the terms: primary health
care, family practice, family physicians, general practitioners.
The complete list of search strategies performed on CENTRAL,
MEDLINE and EMBASE are available in Appendix 1.
CCDAN Registers
The Cochrane Collaboration Depression Anxiety and Neurosis
Group (CCDAN) maintains two clinical trials registers at their
editorial base in Bristol, UK: a references register and a study-based
register. These registers are compiled from routine generic searches
of CENTRAL, MEDLINE, EMBASE, PsycINFO, PSYNDEX,
LILACS, AMED, CINAHL. Details of CCDAN’s generic search
strategies can be found in the ’Specialized Register’ section of the
Group’s module text. For this review, we searched the CCDAN-
CTR Registers using the terms in Appendix 2.
Searching other resources
Citation tracking
We scanned the reference lists of selected studies for screening to
retrieve additional studies that were not identified by the electronic
searches.
Personal communication
We consulted experts in the field to identify any additional, eligible
RCTs (published or unpublished data).
Data collection and analysis
Selection of studies
RH and AHB independently screened the abstracts of the studies
that were identified through the electronic searches. Both authors
independently applied citation tracking.We resolved any disagree-
ment about the selection of a trial by discussion among RH, AHB
and the third review author (CF). In this way we established a final
selection. Because some of the studies were already known to both
review authors, the studies were not blinded before assessment.
Trials in all languages were eligible for inclusion.
Data extraction and management
Two review authors (RH and AHB) independently extracted the
study characteristics of the selected trials. We resolved any dis-
agreement between RH and AHB by discussion among RH, AHB
and CF. We extracted the following study characteristics: method,
study size (number of participants in intervention and control
group), age and gender of participants, number of primary care
physicians, setting (e.g. general practice, occupational health or-
ganization), type of assessment of MUPS and psychiatric co-mor-
bidity, type of intervention and type of control condition (care
as usual or description of intervention in control group), alloca-
tion concealment, blinding (patients, provider, assessor), outcome
measures, effect sizes, withdrawal, conclusions of the authors, and
reported implications for practice.
Assessment of risk of bias in included studies
We assessed methodological quality according to The Cochrane
Collaboration’s Risk of Bias tool (Higgins 2008a). We added
three additional criteria to the Risk of Bias checklist: assessing
MUPSwith validated instruments, a complete description of base-
line characteristics and acceptable pre-randomization dropout (see
Figure 1 for more information). We judged this to be of impor-
tance for the following reasons:
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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• studies assess MUPS in many different ways and not always
with well validated instruments;
• patients with MUPS have high prevalence rates of
psychiatric co-morbidity which, together with socio-
demographic characteristics, are moderators for the effectiveness
of the intervention;
• results might be biased by high pre-randomization dropout
because patients might be reluctant to be referred for psychiatric
screening.
Therefore, the extended checklist consisted of the following in-
ternal validity criteria, with the items rated as yes, no and unclear
indicating low risk of bias, high risk of bias and otherwise.
1. Generation of random allocation sequence
2. Allocation concealment
3. Blinding of patient and outcome assessor
4. Incomplete outcome data addressed
5. Free of selective reporting
6. Free of other bias
7. Complete description of baseline characteristic
8. MUPS assessed with validated questionnaires and/or
structured interviews
9. Acceptable pre-randomization dropout
Measures of treatment effect
All primary and secondary outcomes were continuous, except for
the psychiatric diagnoses made in a psychiatric interview (somato-
form disorders, depression and anxiety disorders), but these were
only given as baseline characteristics. We pooled continuous data
using mean differences whenever outcomes were measured using
the same validated rating scales, and by using standardized mean
differences where outcomes were measured with different or non-
validated rating scales.
If different methods were used to measure the same continu-
ous outcome (e.g. somatization), we extracted standard deviations
from the available information. If this was not available, we calcu-
lated the value according to Chapter 8 of the Cochrane Handbook
for Systematic Reviews of Interventions (Higgins 2008a).Where this
was not possible, we imputed a standard error of studies with the
same intervention in the same population.
Unit of analysis issues
Cluster-randomized trials
For studies with a cluster-randomized design that reported suffi-
cient data to be included in the meta-analysis, and that did not
make an allowance for the design effect, we calculated the design ef-
fect based on a fairly large assumed intra-cluster correlation of 0.05.
Because we did not expect to find information about the intra-
cluster correlation for such studies, we assumed that 0.05 would
be a realistic estimate, according to Chapter 16 of the Cochrane
Handbook for Systematic Reviews of Interventions (Higgins 2008b).
Dealing with missing data
If standard deviationsweremissing, wewould try to calculate them
by using standard errors or confidence intervals for group means.
If standard deviations could not be calculated, we used average
standard deviations reported by other studies for that outcome.We
attempted to perform all analyses to the intention-to-treat (ITT)
principle. For continuous outcomes, if studies did not present last
observation carried forward (LOCF) data, we conducted available
case analyses.
Assessment of heterogeneity
We assessed statistical heterogeneity using the Chi2 statistic, the
associated P value and the I2 statistic. We considered any value
over 30% a possible indication of moderate heterogeneity. If we
found indications of heterogeneity, we would attempt to deter-
mine the potential source, and depending on the cause, we con-
sidered an adequate strategy for dealing with heterogeneity: for ex-
ample, ignoring heterogeneity, not performing the meta-analysis,
or excluding a study.
Assessment of reporting biases
We did not assess for publication bias by means of funnel plots,
because there were not more than 10 studies to be included in the
funnel plot.
Data synthesis
If the study settings, interventions and participants were suffi-
ciently homogeneous, we performed meta-analyses, using relative
risk (RR) as the measure of effect for binary outcomes and mean
difference (MD) or standardized mean difference (SMD) for con-
tinuous outcome measures.
We used a fixed-effect meta-analysis to combine the study data
if trials were considered to be sufficiently similar with respect to
the participants, interventions, outcome measures and timing of
follow-up measurements. We used a random-effects model if the
studies at issue were statistically heterogeneous.
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Subgroup analysis and investigation of heterogeneity
We applied subgroup analyses if the following clinically relevant
patient or intervention characteristics could be identified in an
RCT.
1. Setting - general practice versus occupational health setting
2. Diagnostic criteria applied:
- patients with MUPS in the form of somatoform disorders ac-
cording to DSM-IV criteria (APA 1994) or a subthreshold so-
matoform disorder;
- patients with somatoform disorders according to DSM-IV cri-
teria (APA 1994) or patients with MUPS according to other or
non-validated criteria.
Sensitivity analysis
We applied sensitivity analyses to the following key criteria and
assumptions.
1. Study quality - removal of studies with low quality (based on
risk of bias assessment): removal of studies with four or more items
rated as high risk of bias in the quality assessment.
2. Imputation of missing data based on assumptions about out-
come: imputation of standard errors from studies with the same
intervention in a comparable patient population.
3. Application of Intention-to-treat (ITT) principles. For missing
patients imputing data, if data were present on patient level, as if
they would have completed the study.
R E S U L T S
Description of studies
Results of the search
The electronic searches yielded 3897 references. We screened all
on title and abstract and excludedmost, because the abstract made
clear that the study was not a RCT, or the intervention was not
a CL. Finally, we screened 31 full-text articles for eligibility, four
of which we identified through personal communication with ex-
perts in the field and through tracking references. The experts we
contacted also mentioned three ongoing RCTs.
Of the final 31 articles, 17 articles described 14 studies. Four
secondary articles (Smith 1986b; Katon 1990; Kashner 1992;
Dickinson 2003) provided additional data on four main articles
that described four RCTs (Smith 1986a; Katon 1992; Rost 1994;
Dickinson 2003). Of the 14 trials, six met eligibility criteria for
inclusion in the review (Smith 1986; Katon 1992; Rost 1994;
Smith 1995; Dickinson 2003; Van der Feltz 2006). We contacted
the lead authors of these studies for additional information and
unpublished data. All but one of the authors responded to our
requests, and four of them could not provide additional data be-
cause their study periods were before 1996 and the data had not
been stored.
Eight of the final 14 studies did not meet inclusion criteria
(Meeuwesen 1994; Carr 1997; Koopmans 1996; Barsky 2004; De
Cruppe 2005; Allen 2006; Escobar 2007; Liu 2007); we excluded
all of these.
Included studies
Wewere able to divide the included studies into twogroups accord-
ing to the intervention applied: four studies about separate psychi-
atric screening (Smith 1986; Rost 1994; Smith 1995; Dickinson
2003) and two studies about joint consultation of the psychiatrist
and primary care physician with the patient, before providing a
CL (Katon 1992; Van der Feltz 2006). We have summarized the
main characteristics and outcomes of the included studies in the
Characteristics of included studies.
Study design and length of study
The four studies which compared the CL to care as usual (CAU)
all had a cross-over design (Smith 1986; Rost 1994; Smith 1995;
Dickinson 2003). We only included results from before the cross-
over, because only during that period could the intervention con-
dition be compared with the control condition. We judged that
after cross-over there would be carry-over effects. Including first
phase data of cross-over trials might introduce potential bias, be-
cause the report can be based on test of carry over, incomplete
data from the control condition and such designs can be under-
powered. However, the reports in the four studies on these top-
ics were transparent and the risk of this kind of bias was judged
to be limited. The time points for cross-over were at 12 months
for three studies (Rost 1994; Smith 1995; Dickinson 2003) and
at nine months for one study (Smith 1986). We considered that
these time-points were sufficiently comparable. These four studies
were performed in a primary care setting, and the primary care
physicians were the providers of care.
In both studies comparing joint consultation to CAU there was
cluster randomization. In the high-utilizers study (Katon 1992)
the patients were randomized at physician level. This was the only
study in which the patients were not selected for having somati-
zation symptoms, but because they were distressed, high-utilizing
patients of physicians in primary care clinics. In one study (Van
der Feltz 2006) patients were randomized on practice level. In
both studies the family physicians were the providers of care. The
intervention condition was conducted for a period of 12 months
in the Katon study and six months in the Van der Feltz study.
Intervention
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In four studies (Smith 1986; Rost 1994; Smith 1995; Dickinson
2003), the intervention group received separate psychiatric screen-
ing and only the primary care physician was provided with a CL.
The contents of the CL are described in the Background section.
In two studies (Katon 1992; Van der Feltz 2006), the primary
care physician and a psychiatrist had a joint consultation with the
patient and the CL was tailored to the patient’s diagnosis. In addi-
tion, in the Van der Feltz study patients also received a letter with
recommendations.
In all studies the control condition was CAU, provided by the
primary care physician.
Participants
Participants were recruited fromprimary care. Theywere recruited
from private and university family practices, by the physician (
Smith 1986; Rost 1994; Smith 1995; Van der Feltz 2006) and also
by advertisements in the local media (Rost 1994; Smith 1995). In
one study (Dickinson 2003) an interviewer recruited and screened
patients in the primary care clinic. In another study (Katon 1992),
the patients selected were those in the top 10% of ambulatory
health care visits for their age-sex group. After physicians checked
potential participants against exclusion criteria, these patients were
then recruited by letter and telephone.
Two studies included patients who fulfilled DSM-III criteria
(Smith 1986) or DSM-III-R criteria (Rost 1994) for somatization
disorder (SD). One study (Smith 1995) included patients who
fulfilled criteria for abridged somatization disorder (ASD) (symp-
toms screened with DSM-III-R criteria). One study (Dickinson
2003) included patients who fulfilled criteria for SD, ASD and
multiform somatoform disorder (MSD) (symptoms screened with
DSM-III-R criteria). One study (Van der Feltz 2006) included
patients who fulfilled ICD-10 criteria for somatoform disorders.
One study (Katon 1992) included patients who met criteria for
psychiatric distress (by fulfilling a sum score for anxiety and de-
pression or a score for somatization) or patients who were referred
by the primary care physician for a psychiatric consultation. This
was the only study in which patients who did not fulfil criteria for
somatization using a validated tool were also included; 20.2% of
the patients fulfilled criteria for SD and 73% for ASD. The level of
somatization was high in the population, but it was not specified
to the diagnostic subgroups (e.g. SD, depressive disorder, anxiety
disorder). Therefore, although the study fulfilled the inclusion cri-
teria and almost three-quarters of the patients fulfilled criteria for
ASD, the results of our review are also given in a subgroup analysis
without this study.
Exclusion criteria were: not living within 72 kilometres of the
study location (Smith 1986); in Rost 1994 and Smith 1995 they
were the physician not agree to participation, no transportation
to the medical centre, moving during the study and the treating
physician having participated in previous studies of the authors; in
Katon 1992 they were pregnancy, psychosis, dementia and patient
not known to physician. Van der Feltz 2006 employed the same
exclusion criteria as Katon, and in addition excluded participants
on the basis of suicidality, alcohol dependency, current psychiatric
treatment, age under 18 and being unable to fill out the question-
naire. Dickinson 2003 reported no exclusion criteria.
Cultural setting and period
The studies which compared CL to CAU were performed in the
United States of America (USA). Three studies were performed
before 1995 (Smith 1986; Rost 1994; Smith 1995) and one study
was undertaken in the past decade (Dickinson 2003). Additionally,
the review authors would like to point out that there is overlap in
the authors of the four studies: Smith performed two of the four
studies with Rost (Rost 1994; Smith 1995) and Rost performed
one study with Dickinson (Dickinson 2003).
The two studies which compared the joint consultation and CL to
CAU were performed in the USA (Katon 1992) and The Nether-
lands (Van der Feltz 2006). The American study was performed
around 1990 and the Dutch study in 2000.
Thereby five of the six studies were performed in the USA and
four of the six studies were performed before 1995.
Sample size
The numbers of patients randomized into the studies varied from
38 (Smith 1986) to 251 (Katon 1992). The total number of pa-
tients included in the six studies was 449; 267 patients were in-
cluded in the four studies regarding the CL; 182 patients were
included in the two studies regarding the joint consultation.
Outcome measures
The primary outcomes reported in the studies were as follows.
Health care (provider)-related
Use of healthcare resources/medical consumption
This was reported in four studies (Smith 1986; Katon 1992; Smith
1995; Van der Feltz 2006). In Smith 1986, this outcome was mea-
sured by asking for information from providers and insurers of
health care about hospital days and outpatient visits. In Smith
1995, the same outcomes plus data on emergency department vis-
its were retrieved from providers and insurers of health care. In
Katon 1992, this was measured by asking the provider of health
care for information about primary care visits, specialty care vis-
its, admission to inpatient medical care, radiography, laboratory
testing services and prescribed medication. In one study (Van der
Feltz 2006), ’medical consumption’ was inventoried according to
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the Visits to Doctors and Other Health Care Professionals (VD-
HCP) scale, which was filled in independently by primary care
physicians as well as the patients.
Medical care costs
Three studies (Smith 1986; Rost 1994; Smith 1995) all reported
costs to the healthcare industry in US dollars.
Patient-related
Severity of somatization
This was reported in two studies. In one study (Katon 1992) it
was measured according to the somatization scale of the Symptom
Checklist Revised (SCL-R) (Derogatis 1974), and in one study
(Van der Feltz 2006) with a checklist that was used in a study
carried out by Speckens 1995.
The secondary outcomes (all patient-related) reported in the stud-
ies were as follows.
Mental functioning
This was reported in four studies (Smith 1986; Rost 1994; Smith
1995; Dickinson 2003). This was measured according to themen-
tal health subscale of the Rand Health Status Measures (Smith
1986; Rost 1994; Smith 1995) and the mental functioning sub-
scale (MCS) of the Short Form-36 (SF-36) (Dickinson 2003). The
Rand and SF-36 scales are almost identical, and can be used for
comparisons.
Physical functioning
This was reported in four studies (Smith 1986; Rost 1994; Smith
1995;Dickinson 2003). This was measured according to the phys-
ical health subscale of the Rand Health Status Measures (Smith
1986; Rost 1994; Smith 1995) and the physical functioning sub-
scale (PCS) of the Short Form-36 (SF-36) (Dickinson 2003). Both
subscales are quite comparable.
Social functioning
This was reported in four studies (Smith 1986; Rost 1994; Smith
1995; Van der Feltz 2006). It wasmeasured in three studies accord-
ing to the social functioning subscale of the Rand Health Status
Measures (Smith 1986; Rost 1994; Smith 1995) and in one study
(Van der Feltz 2006) according to the social interaction subscale
of the Sickness Impart Profile (SIP).
Perceived health
This wasmeasured in three studies (Smith 1986; Rost 1994; Smith
1995) according to the health perceptions subscale of the Rand
Health Status Measures.
Psychiatric comorbidity
This was measured in two studies (Katon 1992; Van der Feltz
2006). In one study (Katon 1992) this was measured according
to the anxiety and depression symptom scales of the Symptom
Checklist Revised (SCL-R) (Derogatis 1974) and in the other
study (Van der Feltz 2006) measured with the anxiety and depres-
sion scales of the Dutch translation of the Symptom Checklist-
90-Revised (SCL-90-R) (Meeuwesen 1992).
Disability
This was measured in two studies (Smith 1986; Katon 1992) by
rating disability days in Smith 1986 and by means of a checklist
measuring chronicmedical conditions and disability (Belloc 1971)
in Katon 1992.
Bed days
This was measured in one study (Smith 1995).
Patient satisfaction
This was measured in one study (Smith 1986).
Excluded studies
We eventually excluded eight of the studies that we initially re-
trieved. In three studies (Meeuwesen 1994; Koopmans 1996; De
Cruppe 2005) the study population consisted of secondary care
patients and the primary care physicianwas not themain caregiver.
In another three studies the ’isolated’ effects of the CL could not
be assessed (Barsky 2004; Allen 2006; Escobar 2007) because the
CL had been used in the intervention group and control group (in
these studies CBT was the main focus of the intervention). The
Barsky study concerned patients with hypochondriasis and not
MUPS. In one study the outcomes regarding somatization were
not measured (Liu 2007). We excluded one study because, after
obtaining the full text article, we discovered that the study design
was not an RCT, but a case-control design (Carr 1997). We have
summarized the excluded studies in Characteristics of excluded
studies.
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Risk of bias in included studies
For the qualification of the risk of bias in the included studies
we used the Cochrane Collaboration’s Risk of Bias Tool (Higgins
2008a), amended to include three extra questions that would assess
the internal validity of the studies: 1.) a complete description of
baseline characteristics and 2.) an assessment of MUPS with vali-
dated instruments and 3.) acceptable pre-randomization dropout.
For the criteria see Table 1. We assessed each item with yes, no or
unclear, implicating low risk of bias, high risk of bias or not clear.
We have provided detailed results of the assessment in the Risk of
Bias tables.
Generation of random sequence
In three studies (Van der Feltz 2006, Katon 1992; Smith 1986) we
found a description of an adequate method of randomization. In
the three other studies (Rost 1994; Smith 1995; Dickinson 2003)
we suspected an adequate method of randomization because of
the mention of randomization and the equal size of the groups,
but we could not find an explicit description and by contacting
the authors we did not obtain an explicit answer. Therefore we
rated this point as ’not clear’.
Allocation
In two studies (Smith 1986; Van der Feltz 2006) we found a
description of adequate concealment of allocation. In the four
other studies (Katon 1992; Rost 1994; Smith 1995; Dickinson
2003) we could not find an explicit description of any method of
concealment and by contacting the authors we did not obtain an
explicit answer. Therefore we rated this point as ’unclear’.
Blinding
We assessed the four studies with the CL intervention as having
low risk of bias for the blinding of patients (Smith 1986; Rost
1994; Smith 1995; Dickinson 2003). In the two studies where
joint consultation was conducted, the blinding of patients was
assessed as having high risk of bias (Katon 1992; Van der Feltz
2006).
We assessed all six studies as having high risk of bias for the blind-
ing of caregivers because the caregivers in the treatment group
knew about the treatment condition because they received the CL,
and in two studies the psychiatrist was also present during the
consultation.
We assessed all studies as having low risk of bias for the blinding
of outcome assessors.
Incomplete outcome data
In three studies with theCL intervention (Smith 1986; Rost 1994;
Dickinson 2003) and the joint consultation for high utilizers study
(Katon 1992), we could not clarify whether or not the results of
patients who were lost to follow-up (in the Dickinson study 20%,
in the other studies 7% or less) were included in the analyses.
Therefore we had to rate this with unclear.
Selective reporting
In none of the six studies did we find clear indications of selective
reporting: all data of intended outcome measures were present
for intervention and control groups during the intervention and
follow-up phases. In the high utilizers study (Katon 1992), the
specific outcomes for patients with somatoform disorders were not
reported, although it is likely that the data were recorded. This was
rated with unclear. The focus in the study was on high utilizers
with distress.
Other potential sources of bias
We found no other sources of bias in five studies. However, in one
(Van der Feltz 2006) there was selection bias, because physicians
decided to stop recruiting patients once they were informed that
their practice was in the CAU group. Therefore, the number of
participants in the intervention group was more than double than
that of the control group.
Adequate description of baseline characteristics
All studies gave an adequate description of the baseline character-
istics of the sample population, including psychiatric co-morbid-
ity, sex, age and socio-economic status.
MUPS assessed with validated instruments
All studies used validated instruments and a clinical interview by
psychiatrists or a research assistant to assess and verify the diagnosis
of somatoformdisorders forMUPS in the patients. Further to this,
two studies (Katon 1992; Van der Feltz 2006) used a validated
questionnaire to assess the level of MUPS.
Acceptable pre-randomization dropout
All studies except one (Katon 1992) had an acceptable pre-ran-
domization dropout with percentages below 20%. In four studies
(Smith 1986; Rost 1994; Smith 1995; Van der Feltz 2006) there
was an informal process of screening by the primary care physician
according clear criteria. In one study (Dickinson 2003), there was
screening by the research team and in another study (Katon 1992),
primary care physicians did the first part of the screening and the
research team the second part.
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Effects of interventions
From the included studies we evaluated the effects of two inter-
ventions: ’CL versus CAU’ and ’joint consultation of patient with
the psychiatrist, with the physician present, and CL versus CAU’.
We pooled results of studies that evaluated the same intervention
if there were sufficient data (means, standard deviations, effect
sizes). We measured these results with the same instruments (e.g.
in US dollars regarding costs; subscales of the RAND and SF-
36 for functioning) and therefore the pooled MDs could be re-
ported in weighted MDs. If data were available, but could not be
pooled, we took a narrative approach. There were no comparable
data available for the two comparisons with regard to the primary
outcomes, so we could not perform meta-analysis. If in the fu-
ture comparable data from further studies become available, and
there is not too much heterogeneity, we think that data can be
pooled for the two comparisons because the joint consultation can
be clinically considered as an ’extension’ of the screening by the
psychiatrist before formulating the CL.
Comparison 1: CLs versus CAU
Four studies (Smith 1986; Rost 1994; Smith 1995; Dickinson




1.1 Outpatient medical consumption (outpatient visits)
For patients with ASD (Smith 1995) the intervention resulted
in a non-significant difference in outpatient visits (Analysis 1.1).
For patients with SD there were no significant differences in the
number of outpatient visits (Smith 1986).
1.2 and 1.3 Inpatient medical consumption (emergency
department visits, hospital days)
For patients with ASD (Smith 1995) the intervention resulted
in a non-significant difference in emergency department visits (
Analysis 1.2) and a non-significant difference in hospital days (
Analysis 1.3).
For patients with SD (Smith 1986) there was a significant reduc-
tion in hospital days (P = < 0.01). Pooling for the outcomes of
inpatient medical consumption was not possible, because of the
difference in outcomes used in each study or because no standard
deviations were reported (Smith 1986).
1.4 Medical costs
For patients with SD (Rost 1994) and ASD (Smith 1995) there
was a reduction in medical costs in US Dollars (MD (fixed) =
352.55 (95%CI -522.32 to -182.78)) (Analysis 1.4). This is in
line with the results reported by Smith 1986 (this study could
not be used for pooling because Smith reported means and no
standard deviations) where in the intervention condition there
was a reduction of 617 US Dollar from the median base line
value, mainly due to a reduction in hospital days. The reductions
reported in the studies were 53% (Smith 1986), 45% (Rost 1994)
and 32.9% (Smith 1995) of annual median medical charges.
Patient-related
1.5 Number and severity of somatization symptoms
The number and severity of theMUPS or somatization symptoms
were not measured in the four studies during or after the inter-
vention.
Secondary outcomes
1.6 Sick leave and return to work
There were no details about sick leave and return to work in the
studies.
1.7 Functional status
Wewere able to sub-divide functioning into outcomes for physical,
mental and social functioning as follows.
1.7.1 Physical functioning
For physical functioning (measured according to the correspond-
ingRANDsubscale) the studies concerningpatientswith SD(Rost
1994;Dickinson 2003), ASD (Smith 1995) andMSD (Dickinson
2003) all reported an increase in physical functioning (MD (fixed)
= 5.71 (95% CI 4.11 to 7.31)) (Analysis 1.5). However it should
be noted that there is an overlap between the subgroups with a SD,
ASD and MSD in the Dickinson study. Because of 95.5% over-
lap between the MSD subgroup and the SD and ASD subgroups
and comparable confidence intervals (Dickinson 2003), this will
not have had any great influence on the MD and could only have
decreased the MD slightly, because of the greatest effect in the
SD subgroup and smaller and comparable effects in the ASD and
MSD subgroups. Crucially, the baseline scores (physical function-
ing, mental functioning, race, age, gender, education) in the three
subgroups were quite comparable (Dickinson 2003). For patients
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with SD, Smith 1986 reported a non-significant difference (no
standard deviations reported).
1.7.2 Mental functioning
For patients with SD there was an non-significant difference in
mental functioning (Rost 1994) and the same was true for patients
with ASD (Smith 1995). The pooled effect resulted in a small
decrease (MD (fixed) -0.66 (95% CI -2.21 to 0.9)) (Analysis
1.6). For patients with SD, Smith 1986reported a non-significant
difference (no standard deviations reported).
1.7.3 Social functioning
The studies concerning patients with SD (Rost 1994) and ASD
(Smith 1995) reported non-significant differences in social func-
tioning (MD (fixed) -0.99 (95%CI -2.64 to 0.66)) (Analysis 1.7).
For patients with SD, Smith 1986 reported a difference of -13
(P < 0.01, no standard deviations reported) for the mean of the
intervention condition compared to the control condition. On
other scales for social functioning for patients with SD, Rost 1994
reported a non-significant increase in the scale of lack or role lim-
itations (RAND subscale).
1.8 Health perceptions
There were non-significant differences in health perceptions in
the intervention condition for patients with SD (Rost 1994) and
ASD (Smith 1995) (MD (fixed) -2.13 (95% CI -4.33 to 0.08))
(Analysis 1.8). In the other study with patients with SD (Smith
1986), there was no difference in perceived health after the inter-
vention period. Because Smith reported no standard deviations,
this outcome could not be used for pooling.
1.9 Depression and anxiety measures
Psychiatric comorbidity




One study (Smith 1986) for patients with SD disorder reported a
non-significant difference of disability days for the patients in the
intervention condition.
Bed days
For patients with ASD, Smith 1995 reported a non-significant
difference of bed days.
Patient satisfaction
For patients with SD, Smith 1986 reported no changes in patient
satisfaction.
Comparison 2: Joint consultation of psychiatrist and
physician and consultation letter versus CAU
Primary outcomes
In two studies (Katon 1992; Van der Feltz 2006), one of which
was a cluster level RCT (Van der Feltz 2006), the intervention
concerned a joint consultation of the patient with the psychiatrist
in presence of the physician, followed by a CL. The two studies
could not be pooled because Katon 1992 did not provide detailed
information about standard deviations. In the only study (Van
der Feltz 2006) with cluster randomization, there was such a low
variance between primary care physician practices (0.117) that we
considered correction for the design effect not necessary in the
meta-analysis.
Health care (provider)-related
2.1 Primary care medical consumption
There was a reduction in the use of health care in general practices
in the patient group with SD (Van der Feltz 2006) (MD (fixed)
-9.85 (95% CI -15.19 to -4.52)) (Analysis 2.1). In the patient
group of distressed high utilizers (Katon 1992), there were no sig-
nificant differences in primary care, radiography and laboratory
testing services between the intervention and control group. In this
second study, the only significant effect was seen in the percent-
age of intervention patients who used an antidepressant, longer-
term use of antidepressants and percentage of rate of prescribing
antidepressants by the ’intervention physicians’.
2.2 Total health care medical consumption
There was a reduction in use of total health care in the patient
group with somatoform disorders (Van der Feltz 2006) (MD
(fixed) = -95.97 (95% CI -148.71 to -43.23)) (Analysis 2.2). For
the patient group of distressed high utilizers (Katon 1992) there
were non-significant effects for specialist care visits, admission to
inpatientmedical care, radiography and laboratory testing services.
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Patient-related
2.3 Severity of somatization symptoms
Van der Feltz 2006 reported a reduction of somatization symptom
severity (SCL-90) in the patient group with different kinds of
somatoform disorders (Analysis 2.3). Katon 1992 reported for a
group of distressed high utilizers, inwhich 73%fulfilled the criteria





There was a significant improvement in social functioning in the
patient group with somatoform disorders (measured with the sub-
scale of the Sickness Impact Profile) (Van der Feltz 2006) (Analysis
2.4). There was a non-significant change in disability in the group
of distressed high utilizers (Katon 1992).
2.5 Depression and anxiety measures
Psychiatric comorbidity
Both studies reported non-significant changes in psychiatric co-
morbidity.
Subgroup analysis
Effects of CL in SD versus ASD and MSD
We used the results of Comparison 1 for this subgroup analysis.
Health care (provider) related outcomes were reported on primary
outcomes only. For patients with SD (Rost 1994) and ASD (Smith
1995), there was a reduction in medical costs in US dollars (MD
(fixed) 352.55 (95% CI -522.32 to -182.78)) (Analysis 1.4). The
reductions reported in the studies were 45% for patients with SD
(Rost 1994) and 32.9% for patients with ASD (Smith 1995) of
annual median medical charges.
Patient-related outcomes were reported on secondary outcomes
only. For physical functioning, the strongest improvement was
achieved in patients with SD (Rost 1994; Dickinson 2003) (MD
(fixed) 7.57 (95% CI 4.04 to 11.09)) compared to patients with
MSD (Dickinson 2003) (MD (fixed) 5.50 (95%CI 2.45 to 8.55))
and ASD (Smith 1995; Dickinson 2003) (MD (fixed) 5.07 (95%
CI 2.81 to 7.33)) (Analysis 1.5). For mental functioning, so-
cial functioning and health perceptions there were non-significant
changes (except mental health in patients with SD (Rost 1994) -
a reduction) in the diagnostic subgroups.
Effects of joint consultation and CL in patients with
somatoform disorders versus patients with distressed high
utilizers
The distressed high utilizers study (Katon 1992) reported non-sig-
nificant changes for the primary outcomes of somatization (SCL
scale) and medical consumption (doctor visits, laboratory test-
ing, radiography). This was also the case for the secondary out-
comes mental health (SCL depression, SCL anxiety) and disabil-
ity. Therefore the results of Comparison 2 can be used, which
showed only significant results in one study (Van der Feltz 2006):
a reduction of severity of somatization symptoms, primary care
and total healthcare consumption and an improvement in social
functioning in patients with somatoform disorders.
In our protocol we listed the following issues that could be relevant.
• Differences between patients from general practice versus
occupational health practice: there were no studies carried out in
occupational health settings.
• Differences between patient groups with a SD, ASD and
MSD for one outcome. For the intervention ’CL versus CAU’,
the reduction in medical costs was stronger in patients with a
SD, than in patients with ASD, as was the improvement in
physical functioning.
• Differences between patient groups with diagnosed
somatoform disorders versus all other forms of MUPS: this
analysis added nothing to the conclusions about the effectiveness
of the joint consultation.
Sensitivity analysis
Effects of CL in SD versus ASD and MSD for medical costs
and physical functioning with imputed data for one study
with SD
Of the primary outcomesmedical costs andphysical symptoms,we
could not pool for one study (Smith 1986) because no standard de-
viations were reported. According to our protocol we used the out-
comes of the two other studies reporting results on these outcomes
for patients with SD (Rost 1994; Dickinson 2003). For medical
costs we imputed the SE from one study (Rost 1994) and for phys-
ical functioning we imputed a pooled SE from both studies. For
medical costs, after imputing the SE, the pooled reduction in US
dollars was 422.36 (MD (fixed) (95% CI -568.01 to -276.71),
with the reduction in patients with SD being 541.50 (MD (fixed)
(95% CI -741.96 to -341.04)) and in patients with ASD 289.11
15Consultation letters for medically unexplained physical symptoms in primary care (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(MD (fixed) (95% CI -501.10 to -77.12)). See Analysis 3.1. For
physical functioning, after imputing of the pooled SE, the pooled
improvement was 3.57 (MD (fixed) (95% CI 2.07 to 5.07), with
the improvement in patients with SD being 0.02 (MD (fixed)
95% CI -2.64 to 2.68), in patients with ASD 5.07 (MD (fixed)
95% CI 2.81 to 7.33 ) and MSD 5.50 (MD (fixed) 95% CI 2.45
to 8.55). See Analysis 3.2.
In our protocol we also listed the following issues that could be
relevant:
• differences between studies with moderate and low risks of
bias versus studies with high risks of bias: there were no studies
considered to have a high risk of bias;
• assessment of publication bias: we did not investigate this
with a funnel plot, because there were fewer than 10 studies;
• for patients with SD the reduction in medical costs was
stronger after using the outcome of one study (Smith 1986) with
imputing the standard error from another study (Rost 1994). For
patients with SD the improvement in physical functioning
disappeared after using the outcome of one study (Smith 1986),
with imputing the pooled standard error from two other studies
(Rost 1994; Dickinson 2003).
Heterogenity
We found no statistical indications for possible substantial hetero-
geneity and therefore undertook no decisions relevant to this.
D I S C U S S I O N
Summary of main results
CL intervention
With regard to the CL intervention, the primary outcomes in the
four studies showed a reduction in medical costs (three studies
reported on this outcome). The reduction was greater for patients
with SD (Smith 1986; Rost 1994) than for patients with ASD
(Smith 1995): in percentages thesewere reductions inmedian costs
of 53%, 45% and 32.9% (costs for psychiatric care excluded).
The reductions were mainly due to smaller reductions in types of
inpatient medical consumption, with one study reporting a clear
reduction in hospital days for patients with a SD (Smith 1986).
The secondary outcomes showed an improvement in physical
functioning for the patients with a SD, ASD andMSD.One study
(Smith 1986) reported that for patients with a SD there was a re-
duction of physical functioning, but these data could not be used
for pooling because there were no reported standard deviations.
With use of an imputed SE for the outcome of this study, the
pooled data still showed an improvement in physical functioning,
but no longer an improvement in the subgroup of patients with
SD. Formental, social functioning and perceived health there were
non-significant differences. There was a small reduction in per-
ceived health. There were no data on sick leave or return to work.
Joint consultation and CL
Two studies reported on the intervention the joint consultation
followed by a CL. In patients with somatoform disorders (Van
der Feltz 2006) there were significant improvements in severity
of somatization symptoms, medical consumption and social func-
tioning. In the group of distressed high utilizers (Katon 1992), in
which 73% fulfilled the criteria for ASD, there were no indications
of effect of the intervention. In the intervention group in this study
there were significant improvements in the use of antidepressants,
the long-term use of antidepressants, and the antidepressant pre-
scription rate among the physicians.
In conclusion, there is evidence that the use of a CL in primary
care, in the treatment of patients with multiple MUPS, results in
reduced medical costs (for SD and ASD) and improved physical
functioning (for SD, ASD, MSD) with the strongest effects on
SD, which is the most severe but also most rare disorder, regarding
medical costs.
There is limited evidence that the use of a CL letter in primary
care results in reduced inpatient medical consumption in patients
with somatoform disorders
There is limited evidence that in primary care joint consultation
with the patient with multiple MUPS by a psychiatrist, in the
presence of the primary care physician, results in reduced symp-
tom severity, reduced medical consumption and improved social
functioning in patients with somatoform disorders
Overall completeness and applicability of
evidence
Limitations
Some remarks should be made about the limitations in external
validity:
Clinical relevance
First of all, two of the six studies (Smith 1986; Rost 1994) con-
cerned patients with a SD. This disorder is rare in primary care,
with a prevalence of approximately 0.5% (DeWaal 2004). This is
in contrast to sub-threshold somatoform disorders, with a preva-
lence of 10-24% (Escobar 1998; Kroenke 2002; De Waal 2004).
Therefore more weight should be given to the results in the pa-
tient groups with sub-threshold forms, showing less reduction in
medical costs and less improvement of physical functioning than
the patient groups with somatization disorder.
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Health care setting, period
Five of the six studies were performed in the United States (the
other study was performed in the Netherlands), so the results in
other countries could vary considerably, due to differences in the
role of the primary care physician and the insurance policies.
The outcomes which are reported in the studies vary. Concern-
ing the main pathology, two studies reported on the severity of
somatization symptoms and psychiatric comorbidity. The other
four studies focused on SD, ASD and MSD, for which a lifetime
history or a two-year history of MUPS and a symptom count is
sufficient.
None of the studies were performed in an occupational health set-
ting and there were no data on sub-populations of employees, so
no conclusions can be drawn on the effect of the intervention for
employees regarding return to work or functioning at work. The
results show an effect on improving physical functioning and a
small effect on reducing social function, which can be of impor-
tance in the functioning and return to work of employees, but no
conclusions can be drawn with regard to the exact effects.
Furthermore, it should be borne in mind that four of the six in-
cluded studies were from 1995 and earlier. The results of these
studies are well known to many medical professionals, and health
care has changed a lot since then. For example, the average dura-
tion of hospital admissions is greatly reduced. These are two rea-
sons why these interventions will probably no longer achieve the
same effect sizes.
Physician- versus patient-centred aspects
The interventions described in these studies are mainly physician-
centred interventions. Only Van der Feltz 2006 included a letter
for the patient. Furthermore, four of the six studies did not mea-
sure patient-centred outcomes like symptom severity as primary
outcomes or patient satisfaction as a secondary outcome. So this
gives little insight as to how the patient-centred aspects of these
interventions could be improved. In the light of the perceived re-
duced general health status of patients with persisting MUPS, this
leaves room for further improvement.
Components of the intervention
There are three important aspects of interventions for patients
with multiple and recurrent somatization symptoms: psychiatric
screening, case management (e.g. regular appointments, and lim-
iting referrals and diagnostic procedures) and patient-physician
communication (e.g. take the patient seriously, don’t tell the pa-
tient “it ’is all in your head”, make a physical examination). From
the results of our review it is not possible to draw any conclusions
with regard to which aspects contributed most to the favourable
outcomes. Further research is needed, but in the meantime atten-
tion must be paid to all three aspects.
Strengths
Strengths of the included studies, with regard to external validity,
were that the study patients were of all ages, except children, and
with a gender distribution comparable to what is reported in other
studies concerning somatoform disorders. All the studies were per-
formed in primary care, and urban and rural populations were
involved. Although the results in patients with a SD were greater
than in the patients with less serious somatization syndromes, the
resulting reductions in medical costs and improvements in phys-
ical functioning were still significant. Given the high prevalence
of sub-threshold somatization syndromes, there is a high potential
for improvement in these outcomes in primary care.
Quality of the evidence
We assessed only one study as being of overall high quality (Van
der Feltz 2006) (although see below for details of possible selection
bias) and five studies as only of moderate quality with regard to
internal validity. The conclusions mentioned above were, with
regard to the CL intervention, drawn from four studies with 267
patients in the intervention condition (with 183 patients with
ASD from Dickinson 2003: lower totals for the 111 patients with
MSD, and 88 patients with SD). With regard to the reduction
in medical costs and improvement in physical functioning, these
conclusions are to be interpreted with caution, due to the fact
that these results are established in diagnostic subgroups and lack
transparency in the underlying studies. Furthermore, the results
are varying, with one study in patients with a SD (Smith 1986a)
reporting a negative effect on physical functioning, although this
was in a small study population, and if the results could have been
pooled the results would still have been positive.
The conclusions regarding joint consultation of the psychiatrist
in the presence of the primary care physician, followed by a CL,
concerned two studies with 182 patients in the intervention con-
dition. The patient populations were quite different. The patients
in the study of distressed high utilizers did not all fulfil the inclu-
sion criteria, and there was no subgroup analysis on the patients
who fulfilled the criteria for ASD (73%) and for SD (20.2%). In
the last group there was selection bias, due to the fact that the in-
cluded patients were selected because they were highly distressed,
whereas not all patients with somatoform disorders are distressed.
Therefore conclusions with regard to the effect of consultation
with the psychiatrist, with the use of a CL can only be drawn from
the results of the study with patients with somatoform disorders
(Van der Feltz 2006), providing limited evidence.
One study (Dickinson 2003) showed an important overlap be-
tween the patients with SD, ASD and MSD. A study of patients
fulfilling only the criteria for MSD and not SD and ASD would
have given a clearer indication of the effect of the intervention on
patients with this less serious form of somatoform disorders.
Due to the study design, one study with cluster randomization
(Van der Feltz 2006) had a small control group. Although we as-
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sessed this study of high quality, it should be taken into account
that selection bias could have been of influence, which should be
kept in mind when interpreting the results. In this study there
was heterogeneity of the included patients; for example 34% of
the patients fulfilled the criteria for undifferentiated somatoform
disorder, 25% for persistent pain disorder and 15% for hypochon-
driasis. A strong point is that this heterogeneity reflects the patient
population in primary care.
All studies were of moderate and high quality, and therefore no
analysis was done for the included studies to control for the inclu-
sion of low quality studies.
Potential biases in the review process
For the inclusion of the studies we chose a definition with high
sensitivity and low specificity. The relatively low number of in-
cluded studies indicates that this was probably a good approach.
The intervention consisted of two components (psychiatric screen-
ing and a CL) which we defined in different ways for our search.
It is possible that we missed studies which defined one or two
components in other terms.
One can also argue that our perspective was too narrow. In the field
of consultation-liaison psychiatry, interventions with psychiatric
screening and the use of a CL have evolved to collaborative care
with, amongst other things, the involvement of mental health spe-
cialists and education of the patient. Although this is a promising
development, these are complex interventions to assess in patients
with a broad scale of psychiatric disorders. We chose an interven-
tion with two components and the patient group with MUPS to
obtain insight into the critical components of the effect.
However, one question in our review remains: is there a critical
element in the two components of screening for the diagnosis and
the guidelines for treatment? Does the uncertainty of the diagnosis
hamper the primary care physician providing care for patients
with MUPS? Or does the primary care physician not apply the
recommendations adequately without the ’reminder’ of a CL? To
our knowledge there are no studies which the two components
have been evaluated separately.
We used the Cochrane Collaboration’s Risk of Bias Tool (Higgins
2008a), adding three additional criteria because of the compli-
cated assessment of patients with MUPS, the role of comorbidity
and the potential pre-randomization bias. While we were com-
pleting this review, guidelines for assessing the quality of RCTs
were updated. Using the GRADE approach would have resulted
in a more qualified description of the strength of evidence, and we
recommend using this approach in future revisions. However, we
think that we checked the main factors determining the quality
of the RCTs (Feinstein 1985) and that we detected most risks of
bias. The impossibility of blinding of care providers stays associ-
ated with these kind of interventions, and in analogy blinding can
not be avoided for patients in joint consultations.
Agreements and disagreements with other
studies or reviews
To our knowledge this is the first review on the effectiveness of
CLs. Most reviews on the treatment of patients with MUPS focus
on the effectiveness of cognitive behavourial therapy (CBT) and
antidepressants. A small number of reviews involved the topic of
CLs.
The results of our review are in line with the findings of Looper
and Kirmayer (Looper 2002) in their review of behavioral ap-
proaches to somatoform disorders and the review on the effective-
ness of treatments for somatization in general practice in Blanken-
stein’s thesis (Blankenstein 2001). They reviewed the same stud-
ies as we did (until 2002), although Looper did not include the
Katon study of distressed high utilizers. We found more evidence
than Sumathipala 2007, who stated that there was limited ev-
idence for the effectiveness of CLs for patients with MUPS in
terms of reducing medical health charges and improving physical
functioning. He referred to Rost 1994 and Smith 1995. If our
findings are broadened, they are also in line with the findings of
Henningsen 2007, who performed a review on the management
of functional somatic syndromes (FSS). Earlier research indicates
that there is much overlap in symptoms between the different so-
matic syndromes and somatoform disorders (Wessely 1999). Al-
thoughHenningsen 2007 hadno specific focus onCLs, they stated
that the therapeutic rationale of the effect of non-pharmacologi-
cal treatments (psychotherapy and graded exercise) in FSS is that
these treatments typically aim at overall function and not the alle-
viation of specific symptoms. In this rationale there is overlap with
how the intervention of CL might work in patients with MUPS,
whereas the CL is more aimed at handling the consequences of
MUPS than the causes.
Three reviews show that CBT and antidepressants are the most
effective treatment options for patients with multiple MUPS
(Kroenke 2000; Looper 2002; Sumathipala 2007). However, in-
terpretation of this evidence should take into account that patients
with multiple MUPS vary in their willingness to be referred to a
mental health specialist. In most of the RCTs used for the reviews
there was acceptable compliance, defined in one review as two-
thirds (Looper 2002), but pre-randomization dropout was seldom
described adequately. Furthermore, it is important to remember
that the results of this review are based on five of six studies per-
formed in United States healthcare settings. Outcomes could vary
in other countries with different healthcare settings and, for ex-
ample, more or fewer possibilities at point of use to the consumer.
Applying the recommendations of CLs does not mean that the
patients will be less worried or more satisfied with care. Indeed
our results show that there is a slight reduction in perceived and
general health. The primary care physician should take this into
account and also address the worries of the patient. How to give
good reassurance is still a topic of further investigations, but recent
studies (Epstein 2007; Salmon 2007) have reported that when
physicians reacted on the concerns of patients with MUPS with
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empathy, this resulted in more satisfaction with the patient-physi-
cian relationship.
No direct evidence is available to make it possible to draw con-
clusions on the best care for employees with MUPS, in relation to
their functioning at work and return to work from sick absence.
However, from the evidence obtained from primary care, it can be
concluded indirectly that the diagnosis of MUPS and adherence
to the guidelines will contribute to an improvement in at least
physical functioning. Since interventions result in a reduction in
hospital stays and ’bed days’ it is possible that applying these in-
terventions to employees with MUPS in occupational health care
will lead to a reduction in the period and/or frequency of sickness
absence.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
• There is evidence from studies of moderate quality that the
use of CLs in primary care is effective, but primarily with regard
to healthcare (provider) related outcomes, in reducing financial
costs, and only secondary for patient-related outcomes, in
improving physical functioning.
• There is evidence from studies of moderate quality that if
primary care physicians are taught to take patients with
persistent MUPS seriously, see these patients at regular intervals,
and perform physical examinations at each visit, but do not
make referrals or further investigation unless there is a clear
indication, that this will result in fewer medical costs, less
medical consumption (especially hospital days) and better
physical functioning.
• There is limited evidence that joint consultation with the
patient (by the psychiatrist in the presence of the physician)
results in a reduction of severity of somatization symptoms, less
medical consumption and improved social functioning.
• Other interventions are needed when psychiatric
comorbidity, mental functioning, social functioning and
disability are (also) to be addressed in patients with somatization
symptoms.
• Other health care professionals should be careful with
referrals and diagnostic procedures for patients with somatization
symptoms, and should first communicate with the primary care
physician. Furthermore, in caring for these patients, attention
should be paid to the management of communication (as
mentioned in the CL).
Implications for research
Further RCTs and studies are needed to address the following
issues:
• To evaluate both the CL intervention and the CL
intervention with joint consultation with the patient, with
emphasis on the severity of somatization symptoms, psychiatric
comorbidity, functioning and patient satisfaction as outcomes.
• To assess pre-randomization dropout rates.
• To clarify how a diagnosis of somatoform disorders or
MUPS helps in the therapeutic choices and communication in
care, and what the critical components are in the
recommendations, with regard to aspects of case management
and communication, preferably by means of qualitative research
and testing tailored interventions in RCTs.
• To tailor the intervention more to the patient’s or
physicians’s perspective, preferably by means of qualitative
research and testing tailored interventions in RCTs.
• To evaluate these interventions in countries with other
healthcare systems than the United States.
• To evaluate these interventions in the field of occupational
health, with physical, mental and social functioning, return to
work, frequency and duration of sickness absence of employees
as primary outcomes.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Dickinson 2003
Methods RCT to compare two conditions. Randomization at patient level. Assessments on three
occasions: baseline, 6 and 12 months after enrolment. After 1 year single cross-over for
the patients in the control condition
Participants 188 patients with somatoform symptoms, from 3 primary care clinics, who were reclas-
sified into three groups, meeting criteria for
1) somatization disorder (SD; n = 88, mean age 46.9 years, standard deviation 15.9
years)
2) abridged somatizationdisorder (ASD; n=183,mean age 47.5 years, standard deviation
14.9 years)
3) multisomatoform disorder (MSD; n = 111, mean age 46.6 years, standard deviation
15.3 years)
Interventions a) Screening: by an interviewer who used an 11-item screening for unexplained physical
symptoms. For all patients with 3 or more positive items on the screening, a diagnostic
interview was performed by a trained interviewer, using the somatization section of the
NIMHDiagnostic Interview Schedule (DIS) Version III-R. The results were reviewed by
the study physician to confirm that the physical symptoms were medically unexplained.
Patients were selected if they fulfilled the criteria for SD, ASD or MSD.
b) Intervention: the family physicians of patients of the intervention group were sent a
Care Recommendation letter about the patients who met the criteria for a somatoform
disorder. This letter consisted of the components mentioned in theNotes of Smith 1986.
Outcomes 1 year follow-up: intervention (I) superior to control (C) on physical functioning (SF-
36: PCS) in all 3 groups. No differences in mental functioning (SF-36: MCS) in all 3
groups
Notes Lost to follow-up 37/188 (no specification I or C and SD, ASD or MSD)
Study location: Mobile, Alabama, USA.
Study period: 1992-1997.
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Only the randomization is mentioned, not
the method by which it is performed
Allocation concealment? Unclear risk Not mentioned in the study text
Blinding?
Blinding of patients?
Low risk For patients and outcome assessors, not for
providers of care due to type of intervention
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Dickinson 2003 (Continued)
Incomplete outcome data addressed?
All outcomes
Unclear risk No significant differences on baseline char-
acteristics for responders and non-respon-
ders. 19.5% and 39.5% non-responders at
12 and 24 months respectively, with no re-
port on distribution over I andC group.No
imputation for loss to follow-up reported
Free of selective reporting? Low risk Expected outcomes present; only physi-
cal and mental functioning were measured,
but this was intended
Free of other bias? Low risk Cross-over design, but complete data I and
C for first and second phase, which enabled
assessment of carry-on effects
Complete description of baseline charac-
teristics?
Low risk Psychiatric co-morbidity, age, sex and so-
cio-economic status
WereMUPS assessedwith validated instru-
ments?
Low risk Clinical interviewer applying the DIS
(DSM-III-R-version).
Was there an acceptable pre-randomisation
dropout?
Low risk Patients were first screened by primary
care physicians (from top 10% ambulatory
healthcare visits from registrations) and af-
ter that by a research team. From the pa-
tients fulfilling the screening criteria, 6.7%
refused to be randomized, in total 14% did
not participate in randomization, due to
inability to contact and other difficulties.
Characteristics of refusers not described
Katon 1992
Methods RCT to compare two conditions. Randomization stratified at physician level.
Assessment on three occasions: baseline, 6 and 12 months.
Participants Total 251 patients, I: 124 patients C: 127 patients (mean age I 45.1 years, SD 12.6
years, and C 48.9 years, SD 14.1 years) from 2 primary care clinics whose health care
utilization placed them in the top 10% and who met any of three screen criteria for
psychiatric distress. 20.2% fulfilled the criteria for SD
Interventions a) Screening on 3 criteria:
1) Sum of SCL item scores for anxiety and depression scores greater than 13
2) Sum of SCL somatization score greater than 9.
3) Referral from the primary care physician for psychiatric consultation
Patients who met any of the three screening criteria were interviewed for 1 hour by a
study psychiatrist using the NIMH DIS version 3 A.
b) Intervention: The patient was interviewed for half an hour by the study psychiatrist
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Katon 1992 (Continued)
with the primary care physician present. The primary care physician was provided with
a written psychiatric CL, a brief written protocol for recommended treatment and an
article on treatment of the specific mental disorder. During the course of the study
the study psychiatrist had one meeting with the participating physician to review the
management of the patient
Outcomes 1 year follow-up: I no significant differences compared to C with regard to medical
consumption, somatization, mental health or disability, except in I higher prescription
rate for antidepressant medication and higher sustained use by patients, compared to C
Notes Lost to follow-up 18/251 (I: 9/124, C: 9/127).
Study location: Western Washington State Arkansas, USA.
Study period: Not specified, before 1992.
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Stratified by physician.
Allocation concealment? Unclear risk Only short description of the randomiza-




High risk Due to type of intervention physicians and
patients not blinded, outcome assessors
were blinded
Incomplete outcome data addressed?
All outcomes
Unclear risk No imputation for loss to follow-up re-
ported.
Free of selective reporting? Unclear risk Expected outcomes present, but not speci-
fied for patients with somatoform disorders
without explicit reasons for this
Free of other bias? Low risk No indications of other bias found
Complete description of baseline charac-
teristics?
Low risk Psychiatric co-morbidity, age, sex and so-
cio-economic status
WereMUPS assessedwith validated instru-
ments?
Low risk By psychiatrist and SCL-90 questionnaire.
Was there an acceptable pre-randomisation
dropout?
High risk 26% of the selected patients did not partic-
ipate in randomization. Reasons were not
mentioned. Refusers were less depressed
and disabled than participants
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Rost 1994
Methods RCT to compare two conditions. Randomization at physician level. Assessment on 4
occasions: baseline, 4, 8 and 12 months
Participants 73 patients I: 40 patients, C: 33 patients (mean age I 44.6 years, standard deviation 8.5
years, and C 43.4 years, SD 10.0 years) from primary care practices fulfilling the criteria
for SD. Care provided by 59 primary care physicians
Interventions a) Screening: by means of a semi-structured interview with the research assistant and
a checklist with DSM-III-R criteria for SD. The research psychiatrist determined the
number of unexplained medical symptoms.
b) Intervention: the physicians in the I-group received a CL (see Notes Smith 1986).
Outcomes 1 year follow-up: I superior to C on medical costs (US Dollars) and physical functioning
(Rand physical health). No significant differences in mental functioning (Rand mental
health)
Notes Lost to follow-up 3/73 (no specification I or C).
Study location: Central Arkansas, USA.
Study period: not specified (before 1995, all costs reattributed to 1990 dollars)
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Only the randomization is mentioned, not
the method by which it is performed




Low risk For patients and outcome assessors, not for
providers of care due to type of intervention
Incomplete outcome data addressed?
All outcomes
Unclear risk No imputation for loss for follow-up re-
ported.
Free of selective reporting? Low risk Expected outcomes are presented
Free of other bias? Low risk Cross-over design, but complete data for
I and C for first and second phase, which
enables assessing carry-on effects
Complete description of baseline charac-
teristics?
Low risk Psychiatric co-morbidity, age, sex and edu-
cation.
WereMUPS assessedwith validated instru-
ments?
Low risk By psychiatrist.
27Consultation letters for medically unexplained physical symptoms in primary care (Review)
Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Rost 1994 (Continued)
Was there an acceptable pre-randomisation
dropout?
Low risk After selection by primary care physicians,
all selected patients who met the study cri-
teria participated in randomization
Smith 1986
Methods RCT to compare two conditions. Randomization at physician level. Assessment on 2
occasions: baseline, 9 months. After 9 months single cross over for the control condition
Participants 38 patients I: 19 patients, C: 19 patients (mean age I 45 years, standard deviation 11.
5 years, and C 44.8 years SD 13.9 years) from private and university family practices,
fulfilling the criteria for SD. Care provided by 35 primary care physicians
Interventions The CL described the diagnosis of SD, its chronic relapsing course, and its lowmortality
and morbidity rates. It also contained recommendations for management and suggested
that:
- Regulary appointments should be made for the patient (possibly every 4 to 6 weeks)
- Physical examinations should be performed at each visit, so that the symptoms would
not be taken at face value
- Physicians should avoid hospitalization of the patient, diagnostic procedures, surgery
and the use of laboratory assessments unless they were clearly indicated
- Physicians were encouraged not to tell patients “it’s all in your head”
Outcomes 9 months follow-up: I superior to C on medical costs (US dollars) and medical con-
sumption (annual hospital days). No significant differences in physical or mental health
(Rand physical and mental health)
Notes Lost to follow-up 3/41 (no specification I or C).
Study location: Central Arkansas, USA.
Study period: 1980-1983.
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Assignment on physician level.
Allocation concealment? Low risk With a sequential log.
Blinding?
Blinding of patients?
Low risk For patients and outcome assessors, not for
providers of care due to type of intervention
Incomplete outcome data addressed?
All outcomes
Unclear risk No imputation for loss for follow-up re-
ported.
Free of selective reporting? Low risk Expected outcomes are presented
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Smith 1986 (Continued)
Free of other bias? Low risk Cross-over design, but complete data for
I and C for first and second phase, which
enables assessing carry-on effects
Complete description of baseline charac-
teristics?
Low risk Psychiatric co-morbidity, sex, age and so-
cio-economic class.
WereMUPS assessedwith validated instru-
ments?
Low risk By psychiatrist.
Was there an acceptable pre-randomisation
dropout?
Low risk After selection by primary care physicians,
7.3% of the selected patients who met the
study criteria refused participation in ran-
domization
Smith 1995
Methods RCT to compare two conditions. Randomization at physician level. Assessment on 4
occasions: baseline, 4 months, 8 months and 1 year. After 1 year single cross over for the
control condition
Participants 56 patients I: 27 patients (mean age 42.2 years, standard deviation 12.3 years) C: 29
patients (mean age 43.9 years, standard deviation 12.5 years) from private and university
family practices. Care provided by 51 primary care physicians
Interventions a) Screening: a semi-structured interview with the research assistant and a checklist
with DSM-III-R criteria for SD. The research psychiatrist determined the number of
unexplained medical symptoms.
b) Intervention: the physicians in the I group received a CL (see Notes Smith 1986).
Outcomes 1 year follow up: I superior to C on medical costs (US dollars) and physical functioning
(Rand physical health). No significant differences in hospital days, outpatient visits or
mental health
Notes Lost to follow-up 2/56 (no specification I or C).
Risk of bias
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Unclear risk Only the randomization is mentioned, not
the method by which it is performed
Allocation concealment? Unclear risk Not mentioned in the study text
Blinding?
Blinding of patients?
Low risk For patients and outcome assessors, not for
providers of care due to type of intervention
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Smith 1995 (Continued)
Incomplete outcome data addressed?
All outcomes
Low risk No subject was missing data for more than
two follow-up periods
Free of selective reporting? Low risk Expected outcomes present.
Free of other bias? Low risk Cross-over design, but complete data for
I and C for first and second phase, which
enables assessing carry-on effects
Complete description of baseline charac-
teristics?
Low risk Psychiatric co-morbidity, age, sex and edu-
cation.
WereMUPS assessedwith validated instru-
ments?
Low risk By psychiatrist.
Was there an acceptable pre-randomisation
dropout?
Low risk After selection by primary care physicians,
all selected patients who met the study cri-
teria participated in randomization
Van der Feltz 2006
Methods RCT to compare two conditions. Randomization at practice level.
Assessment on 3 occasions: baseline, 6 weeks and 6 months.
Participants 81 patients (mean age 44, range 20-77 years) I: 58 patients C: 23 patients. Patients were
receiving care in 36 primary care practices
Interventions a) Screening: by general practitioners who selected patients who fulfilled two criteria:
1) previous referral for symptoms that remain unexplained after specialist diagnostic
examination 2) continuing requests from the patient for further diagnostic procedures.
These patients completed a baseline questionnaire checking ICD-10 criteria for main
categories of somatoform disorders and the Whitely Index.
b) Intervention: The GPs in I and C were given training in case-management, reattri-
bution and cognitive behavioural techniques in 3 to 9 three hours sessions.
The patients had a one-hour interviewwith the psychiatrist in the presence of the primary
care physician. The psychiatrist summarized the diagnosis, reattribution and specific
treatment advice in a CL for both the primary care physician and the patient
Outcomes 6-months follow-up: I superior to C on health care utilization (VDHCP), severity of
main explained medical symptoms (Speckens checklist) and social interaction (SIP)
Notes Lost to follow-up 0/81.
Study location: Amsterdam, The Netherlands.
Study period: 1999-2001 (personal communication authors).
Risk of bias
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Van der Feltz 2006 (Continued)
Bias Authors’ judgement Support for judgement
Adequate sequence generation? Low risk Randomization on practice level.




High risk Due to type of intervention physicians and
patients not blinded, outcome assessors
were blinded
Incomplete outcome data addressed?
All outcomes
Low risk Data complete at follow-up, no non-re-
sponders at follow-up.
Free of selective reporting? Low risk Expected outcomes are presented
Free of other bias? High risk 18 practices provided 58 patients for the I
condition and 18 practices 23 patients for
theC condition because physicians were no
longer blinded for the condition, thereby
potentially enhancing selection bias
Complete description of baseline charac-
teristics?
Low risk Psychiatric co-morbidity, sex, age and so-
cio-economic status
WereMUPS assessedwith validated instru-
ments?
Low risk By psychiatrist and SCL-90 questionnaire.
Was there an acceptable pre-randomisation
dropout?
Low risk After screening by primary care physicians,
from the eligible patients 12% refused
participation in randomization. Refusers
did not differ from participants in demo-
graphic and clinical characteristics
ASD: abridged somatization disorder
C: control
CL: consultation letter
DIS: diagnostic interview schedule
I: intervention
MSD: multisomatoform disorder
NIMH: National Institute of Mental Health
RCT: randomized controlled trial
SD: somatization disorder
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Allen 2006 The ’isolated’ effects of the CL could not be assessed because it was used in the intervention and the controlled
condition
Barsky 2004 The ’isolated’ effects of the CL could not be assessed because it was used in the intervention and the controlled
condition
The patients were selected on criteria for hypochondriasis and not for somatization
Carr 1997 Not an RCT. Case-control design.
De Cruppe 2005 The population was from secondary care and the primary care physician was not the most important caregiver
Escobar 2007 The ’isolated’ effects of the CL could not be assessed because it was used in the intervention and the controlled
condition
Koopmans 1996 The population was from secondary care and the primary care physician was not the most important caregiver
Liu 2007 Outcome for somatization not measured.
Meeuwesen 1994 The population was from secondary care and the primary care physician was not the most important caregiver
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D A T A A N D A N A L Y S E S
Comparison 1. Consultation letter versus CAU




participants Statistical method Effect size
1 Outpatient medical
consumption: outpatient visits
1 Mean Difference (Fixed, 95% CI) 0.20 [-0.38, 0.78]
1.1 Abridged somatization
disorder
1 Mean Difference (Fixed, 95% CI) 0.20 [-0.38, 0.78]
2 Inpatient medical consumption:
emergency department visits
1 Mean Difference (Fixed, 95% CI) -0.7 [-2.72, 1.32]
2.1 Abridged somatization
disorder
1 Mean Difference (Fixed, 95% CI) -0.7 [-2.72, 1.32]
3 Inpatient medical consumption:
hospital days
1 Mean Difference (Fixed, 95% CI) -0.5 [-6.96, 5.96]
3.1 Abridged somatization
disorder
1 Mean Difference (Fixed, 95% CI) -0.5 [-6.96, 5.96]
4 Medical costs 2 Mean Difference (Fixed, 95% CI) -352.55 [-522.32, -
182.78]




1 Mean Difference (Fixed, 95% CI) -289.11 [-501.10, -
77.12]
5 Physical functioning 3 Mean Difference (Fixed, 95% CI) 5.71 [4.10, 7.33]
5.1 Somatization disorder 2 Mean Difference (Fixed, 95% CI) 7.57 [4.04, 11.09]
5.2 Abridged somatization
disorder
2 Mean Difference (Fixed, 95% CI) 5.07 [2.81, 7.33]
5.3 Multisomatoform disorder 1 Mean Difference (Fixed, 95% CI) 5.5 [2.45, 8.55]
6 Mental functioning 2 Mean Difference (Fixed, 95% CI) -0.66 [-2.21, 0.90]
6.1 Somatization disorder 1 Mean Difference (Fixed, 95% CI) 5.0 [-5.30, 15.30]
6.2 Abridged somatization
disorder
1 Mean Difference (Fixed, 95% CI) -0.79 [-2.37, 0.79]
7 Social functioning 2 Mean Difference (Fixed, 95% CI) -0.99 [-2.64, 0.66]
7.1 Somatization disorder 1 Mean Difference (Fixed, 95% CI) -1.7 [-12.55, 9.15]
7.2 Abridged somatization
disorder
1 Mean Difference (Fixed, 95% CI) -0.97 [-2.64, 0.70]
8 Health perceptions 2 Mean Difference (Fixed, 95% CI) -2.13 [-4.33, 0.08]
8.1 Somatization disorder 1 Mean Difference (Fixed, 95% CI) -0.5 [-9.45, 8.45]
8.2 Abridged somatization
disorder
1 Mean Difference (Fixed, 95% CI) -2.23 [-4.50, 0.04]
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Comparison 2. Consult of patient by psychiatrist with the physician present and consultation letter versus care
as usual




participants Statistical method Effect size
1 Primary care medical
consumption
1 Mean Difference (Fixed, 95% CI) -9.85 [-15.18, -4.52]
1.1 Somatoform disorders 1 Mean Difference (Fixed, 95% CI) -9.85 [-15.18, -4.52]
2 Total healthcare medical
consumption
1 Mean Difference (Fixed, 95% CI) -95.97 [-148.71, -
43.23]
2.1 Somatoform disorders 1 Mean Difference (Fixed, 95% CI) -95.97 [-148.71, -
43.23]
3 Somatization symptom severity 1 Mean Difference (Fixed, 95% CI) -1.45 [-1.90, 1.00]
3.1 Somatoform disorders 1 Mean Difference (Fixed, 95% CI) -1.45 [-1.90, 1.00]
4 Social functioning 1 Mean Difference (Fixed, 95% CI) 9.93 [1.48, 18.39]
4.1 Somatoform disorders 1 Mean Difference (Fixed, 95% CI) 9.93 [1.48, 18.39]
Comparison 3. Consultation letter versus CAU with study results imputed for SD




participants Statistical method Effect size
1 Medical costs 3 Mean Difference (Fixed, 95% CI) -422.36 [-568.01, -
276.71]




1 Mean Difference (Fixed, 95% CI) -289.11 [-501.10, -
77.12]
2 Physical functioning 4 Mean Difference (Fixed, 95% CI) 3.57 [2.07, 5.07]
2.1 Somatization disorder 3 Mean Difference (Fixed, 95% CI) 0.02 [-2.64, 2.68]
2.2 Abridged somatization
disorder
2 Mean Difference (Fixed, 95% CI) 5.07 [2.81, 7.33]
2.3 Multisomatoform disorder 1 Mean Difference (Fixed, 95% CI) 5.5 [2.45, 8.55]
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Analysis 1.1. Comparison 1 Consultation letter versus CAU, Outcome 1 Outpatient medical consumption:
outpatient visits.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 1 Outpatient medical consumption: outpatient visits





IV,Fixed,95% CI IV,Fixed,95% CI
1 Abridged somatization disorder
Smith 1995 0.2 (0.2945) 100.0 % 0.20 [ -0.38, 0.78 ]
Total (95% CI) 100.0 % 0.20 [ -0.38, 0.78 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
-2 -1 0 1 2
Favours experimental Favours control
Analysis 1.2. Comparison 1 Consultation letter versus CAU, Outcome 2 Inpatient medical consumption:
emergency department visits.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 2 Inpatient medical consumption: emergency department visits





IV,Fixed,95% CI IV,Fixed,95% CI
1 Abridged somatization disorder
Smith 1995 -0.7 (1.0308) 100.0 % -0.70 [ -2.72, 1.32 ]
Total (95% CI) 100.0 % -0.70 [ -2.72, 1.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.68 (P = 0.50)
Test for subgroup differences: Not applicable
-4 -2 0 2 4
Favours experimental Favours control
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Analysis 1.3. Comparison 1 Consultation letter versus CAU, Outcome 3 Inpatient medical consumption:
hospital days.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 3 Inpatient medical consumption: hospital days





IV,Fixed,95% CI IV,Fixed,95% CI
1 Abridged somatization disorder
Smith 1995 -0.5 (3.296) 100.0 % -0.50 [ -6.96, 5.96 ]
Total (95% CI) 100.0 % -0.50 [ -6.96, 5.96 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.15 (P = 0.88)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Consultation letter versus CAU, Outcome 4 Medical costs.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 4 Medical costs





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatization disorder
Rost 1994 -466 (144.64) 35.9 % -466.00 [ -749.49, -182.51 ]
Subtotal (95% CI) 35.9 % -466.00 [ -749.49, -182.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.22 (P = 0.0013)
2 Abridged somatization disorder
Smith 1995 -289.11 (108.16) 64.1 % -289.11 [ -501.10, -77.12 ]
Subtotal (95% CI) 64.1 % -289.11 [ -501.10, -77.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.67 (P = 0.0075)
Total (95% CI) 100.0 % -352.55 [ -522.32, -182.78 ]
Heterogeneity: Chi2 = 0.96, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 4.07 (P = 0.000047)
Test for subgroup differences: Chi2 = 0.96, df = 1 (P = 0.33), I2 =0.0%
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Analysis 1.5. Comparison 1 Consultation letter versus CAU, Outcome 5 Physical functioning.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 5 Physical functioning





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatization disorder
Dickinson 2003 7.1 (1.8367) 20.1 % 7.10 [ 3.50, 10.70 ]
Rost 1994 17.9 (8.647) 0.9 % 17.90 [ 0.95, 34.85 ]
Subtotal (95% CI) 21.0 % 7.57 [ 4.04, 11.09 ]
Heterogeneity: Chi2 = 1.49, df = 1 (P = 0.22); I2 =33%
Test for overall effect: Z = 4.21 (P = 0.000025)
2 Abridged somatization disorder
Dickinson 2003 4.3 (1.377) 35.7 % 4.30 [ 1.60, 7.00 ]
Smith 1995 6.87 (2.11) 15.2 % 6.87 [ 2.73, 11.01 ]
Subtotal (95% CI) 51.0 % 5.07 [ 2.81, 7.33 ]
Heterogeneity: Chi2 = 1.04, df = 1 (P = 0.31); I2 =4%
Test for overall effect: Z = 4.39 (P = 0.000011)
3 Multisomatoform disorder
Dickinson 2003 5.5 (1.555) 28.0 % 5.50 [ 2.45, 8.55 ]
Subtotal (95% CI) 28.0 % 5.50 [ 2.45, 8.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.54 (P = 0.00040)
Total (95% CI) 100.0 % 5.71 [ 4.10, 7.33 ]
Heterogeneity: Chi2 = 3.93, df = 4 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 6.94 (P < 0.00001)
Test for subgroup differences: Chi2 = 1.40, df = 2 (P = 0.50), I2 =0.0%
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Analysis 1.6. Comparison 1 Consultation letter versus CAU, Outcome 6 Mental functioning.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 6 Mental functioning





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatization disorder
Rost 1994 5 (5.255) 2.3 % 5.00 [ -5.30, 15.30 ]
Subtotal (95% CI) 2.3 % 5.00 [ -5.30, 15.30 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
2 Abridged somatization disorder
Smith 1995 -0.79 (0.8036) 97.7 % -0.79 [ -2.37, 0.79 ]
Subtotal (95% CI) 97.7 % -0.79 [ -2.37, 0.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.98 (P = 0.33)
Total (95% CI) 100.0 % -0.66 [ -2.21, 0.90 ]
Heterogeneity: Chi2 = 1.19, df = 1 (P = 0.28); I2 =16%
Test for overall effect: Z = 0.83 (P = 0.41)
Test for subgroup differences: Chi2 = 1.19, df = 1 (P = 0.28), I2 =16%
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Analysis 1.7. Comparison 1 Consultation letter versus CAU, Outcome 7 Social functioning.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 7 Social functioning





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatization disorder
Rost 1994 -1.7 (5.535) 2.3 % -1.70 [ -12.55, 9.15 ]
Subtotal (95% CI) 2.3 % -1.70 [ -12.55, 9.15 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.31 (P = 0.76)
2 Abridged somatization disorder
Smith 1995 -0.97 (0.852) 97.7 % -0.97 [ -2.64, 0.70 ]
Subtotal (95% CI) 97.7 % -0.97 [ -2.64, 0.70 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.14 (P = 0.25)
Total (95% CI) 100.0 % -0.99 [ -2.64, 0.66 ]
Heterogeneity: Chi2 = 0.02, df = 1 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 1.17 (P = 0.24)
Test for subgroup differences: Chi2 = 0.02, df = 1 (P = 0.90), I2 =0.0%
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Analysis 1.8. Comparison 1 Consultation letter versus CAU, Outcome 8 Health perceptions.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 1 Consultation letter versus CAU
Outcome: 8 Health perceptions





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatization disorder
Rost 1994 -0.5 (4.5663) 6.1 % -0.50 [ -9.45, 8.45 ]
Subtotal (95% CI) 6.1 % -0.50 [ -9.45, 8.45 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
2 Abridged somatization disorder
Smith 1995 -2.23 (1.16) 93.9 % -2.23 [ -4.50, 0.04 ]
Subtotal (95% CI) 93.9 % -2.23 [ -4.50, 0.04 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.92 (P = 0.055)
Total (95% CI) 100.0 % -2.13 [ -4.33, 0.08 ]
Heterogeneity: Chi2 = 0.13, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 1.89 (P = 0.059)
Test for subgroup differences: Chi2 = 0.13, df = 1 (P = 0.71), I2 =0.0%
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Analysis 2.1. Comparison 2 Consult of patient by psychiatrist with the physician present and consultation
letter versus care as usual, Outcome 1 Primary care medical consumption.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 2 Consult of patient by psychiatrist with the physician present and consultation letter versus care as usual
Outcome: 1 Primary care medical consumption





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatoform disorders
Van der Feltz 2006 -9.85 (2.721) 100.0 % -9.85 [ -15.18, -4.52 ]
Total (95% CI) 100.0 % -9.85 [ -15.18, -4.52 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.62 (P = 0.00029)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Consult of patient by psychiatrist with the physician present and consultation
letter versus care as usual, Outcome 2 Total healthcare medical consumption.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 2 Consult of patient by psychiatrist with the physician present and consultation letter versus care as usual
Outcome: 2 Total healthcare medical consumption





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatoform disorders
Van der Feltz 2006 -95.97 (26.91) 100.0 % -95.97 [ -148.71, -43.23 ]
Total (95% CI) 100.0 % -95.97 [ -148.71, -43.23 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.57 (P = 0.00036)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Consult of patient by psychiatrist with the physician present and consultation
letter versus care as usual, Outcome 3 Somatization symptom severity.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 2 Consult of patient by psychiatrist with the physician present and consultation letter versus care as usual
Outcome: 3 Somatization symptom severity





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatoform disorders
Van der Feltz 2006 -1.448 (0.2298) 100.0 % -1.45 [ -1.90, -1.00 ]
Total (95% CI) 100.0 % -1.45 [ -1.90, -1.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.30 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 2.4. Comparison 2 Consult of patient by psychiatrist with the physician present and consultation
letter versus care as usual, Outcome 4 Social functioning.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 2 Consult of patient by psychiatrist with the physician present and consultation letter versus care as usual
Outcome: 4 Social functioning





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatoform disorders
Van der Feltz 2006 9.932 (4.314) 100.0 % 9.93 [ 1.48, 18.39 ]
Total (95% CI) 100.0 % 9.93 [ 1.48, 18.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.30 (P = 0.021)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Consultation letter versus CAU with study results imputed for SD, Outcome 1
Medical costs.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 3 Consultation letter versus CAU with study results imputed for SD
Outcome: 1 Medical costs





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatization disorder
Rost 1994 -466 (144.64) 26.4 % -466.00 [ -749.49, -182.51 ]
Smith 1986 -617 (144.64) 26.4 % -617.00 [ -900.49, -333.51 ]
Subtotal (95% CI) 52.8 % -541.50 [ -741.96, -341.04 ]
Heterogeneity: Chi2 = 0.54, df = 1 (P = 0.46); I2 =0.0%
Test for overall effect: Z = 5.29 (P < 0.00001)
2 Abridged somatisation disorder
Smith 1995 -289.11 (108.16) 47.2 % -289.11 [ -501.10, -77.12 ]
Subtotal (95% CI) 47.2 % -289.11 [ -501.10, -77.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.67 (P = 0.0075)
Total (95% CI) 100.0 % -422.36 [ -568.01, -276.71 ]
Heterogeneity: Chi2 = 3.42, df = 2 (P = 0.18); I2 =42%
Test for overall effect: Z = 5.68 (P < 0.00001)
Test for subgroup differences: Chi2 = 2.87, df = 1 (P = 0.09), I2 =65%
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Analysis 3.2. Comparison 3 Consultation letter versus CAU with study results imputed for SD, Outcome 2
Physical functioning.
Review: Consultation letters for medically unexplained physical symptoms in primary care
Comparison: 3 Consultation letter versus CAU with study results imputed for SD
Outcome: 2 Physical functioning





IV,Fixed,95% CI IV,Fixed,95% CI
1 Somatization disorder
Dickinson 2003 7.1 (1.8367) 17.3 % 7.10 [ 3.50, 10.70 ]
Rost 1994 17.9 (8.647) 0.8 % 17.90 [ 0.95, 34.85 ]
Smith 1986 -10 (2.07) 13.7 % -10.00 [ -14.06, -5.94 ]
Subtotal (95% CI) 31.8 % 0.02 [ -2.64, 2.68 ]
Heterogeneity: Chi2 = 42.57, df = 2 (P<0.00001); I2 =95%
Test for overall effect: Z = 0.01 (P = 0.99)
2 Abridged somatization disorder
Dickinson 2003 4.3 (1.377) 30.9 % 4.30 [ 1.60, 7.00 ]
Smith 1995 6.87 (2.11) 13.1 % 6.87 [ 2.73, 11.01 ]
Subtotal (95% CI) 44.0 % 5.07 [ 2.81, 7.33 ]
Heterogeneity: Chi2 = 1.04, df = 1 (P = 0.31); I2 =4%
Test for overall effect: Z = 4.39 (P = 0.000011)
3 Multisomatoform disorder
Dickinson 2003 5.5 (1.555) 24.2 % 5.50 [ 2.45, 8.55 ]
Subtotal (95% CI) 24.2 % 5.50 [ 2.45, 8.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.54 (P = 0.00040)
Total (95% CI) 100.0 % 3.57 [ 2.07, 5.07 ]
Heterogeneity: Chi2 = 53.68, df = 5 (P<0.00001); I2 =91%
Test for overall effect: Z = 4.66 (P < 0.00001)
Test for subgroup differences: Chi2 = 10.08, df = 2 (P = 0.01), I2 =80%
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A D D I T I O N A L T A B L E S
Table 1. Criteria list for the assessment of methodological quality of included studies
Item ID Description Implementation
Patient selection NOTE: All criteria were scored yes (+), no (-) or
don’t know (?)
1 Was an adequate method of randomization applied? A random (unpredictable) allocation sequence must
have been applied. Methods of allocation based on
date of birth, date of admission, hospital numbers,
or alternation are not considered to be appropriate
2 Was the treatment allocation concealed? Allocation should have been performed by an in-
dependent person who is not responsible for deter-
mining eligibility for inclusion. This person has no
information about the patients included in the trial
and has no influence on the allocation sequence or
the decision about eligibility for inclusion
3 Was there an acceptable pre-randomizationdropout? Pre-randomization dropout rate was less than 20%
after selection on clear criteria
Interventions
4 Were the patients blinded for the intervention? Adequate information about blinding must have
been provided.
5 Were the caregivers blinded for the intervention? Adequate information about blinding must have
been provided.
Outcome measurement
6 Was the outcome assessor blinded for the interven-
tion?
Adequate information about blinding must have
been provided.
7 Was the drop-out/loss to follow-up rate described
and acceptable?
Included patients who did not complete the follow-
up period or were not included in the analysis must
have been described. If the percentage of drop-outs
and loss to follow-up is < 20% for short-term follow-
up and < 30% for long-term follow-up, and loss to
follow-up does not lead to substantial bias, a ’+’ is
scored. (N.B. these percentages are arbitrary, and not
supported by empirical evidence)
8 MUPS were assessed with validated questionnaires
and/or structured interviews
Statistics
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Table 1. Criteria list for the assessment of methodological quality of included studies (Continued)
9 Did the analysis include an intention-to-treat anal-
ysis?
For all randomized patients, themost importantmo-
ments of effect measurement should have been re-
ported/analyzed (minus missing values), irrespective
of non-compliance and co-interventions
A P P E N D I C E S
Appendix 1. MEDLINE, EMBASE and CENTRAL Search Strategies
OVID MEDLINE was searched as follows:
1. exp Somatoform Disorders/











12. (non organic$ or nonorganic$).ti,ab.
13. (unexplain$ adj1 medical$).ti,ab.
14. (unexplain$ adj1 (sympt$ or problem$ or condition$ or complain$)).ti,ab.
15 ((non specific or nonspecific) adj2 (sympt$ or problem$ or condition$ or complain$)).ti,ab.
16. ((unexplain$ or inexpl$) and (health$ or medical$ or physical$) and (sympt$ or problem$ or condition$ or complain$)).ti,ab.
17. frequent$ attend$.ti,ab.
18. (high utilis$ or high utiliz$).ti,ab.
19. or/1-18
20. (functional somatic adj2 (sympt$ or syndr$)).ti,ab.
21. Fibromyalgia/
22. fibromyalgi$.ti,ab.
23. chronic widespread pain.ti,ab.
24. Fatigue Syndrome, Chronic/
25. fatigue syndrome.ti,ab.
26. ((non cardiac or noncardiac or non specific or nonspecific) adj2 chest pain).ti,ab.
27. NCCP.ti,ab.
28. Irritable Bowel Syndrome/
29. (IBS or (irritable bowel syndrome$)).ti,ab.
30. multiple chemical sensitivity.mp.
31. idiopathic environmental intolerance.ti,ab.
32. Premenstrual Syndrome/
33. premenstrual adj2 (syndrome$ or tension$).ti,ab.
34. ((non ulcer nonulcer or functional) adj2 dyspepsia).ti,ab.
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35. exp Cumulative Trauma Disorders/
cumulative trauma disorders/ or carpal tunnel syndrome/ or ulnar nerve compression syndromes/ or cubital tunnel syndrome/
36. cumulative trauma disorder$.ti,ab.
37. repe$ strain injur$.ti,ab.
38. ((tension type or idiopathic or psychogenic) adj2 headache$).ti,ab.
39. exp Temporomandibular Joint Disorders/
(temporomandibular joint disorders/ or temporomandibular joint dysfunction syndrome/)
40. ((temporomandibular joint or TMJ) adj2 (disease$ or disorder$ or dysfunction$)).ti,ab.
41. or/20-40
42. 19 or 41
43. interdisciplinary communication.mp.
44. multidisciplinary communication.ti,ab.
45. exp Correspondence as Topic/




49. exp “Referral and Consultation”/
(“referral and consultation”/ or ethics consultation/ or gatekeeping/ or physician self-referral/ or remote consultation/)







57. randomized controlled trial.pt.





63. (clinic$ adj3 (trial$ or study or studies$)).ti,ab.
64. ((singl$ or doubl$ or tripl$) adj (blind$ or mask$ or dummy)).ti,ab.
65. (control$ or prospectiv$ or volunteer$).ti,ab.
66. or/57-65
67. exp animals/ not humans.sh.
68. 66 not 67
69. 68 and 42
Search terms for Consultation-Liaison Psychiatry and Primary Care:
70. (consultation liaison adj2 psychiatr$).ti,ab.
71. C-L psychiatr$.ti,ab.
72. Primary health care/
73. Family practice/
74. ((general or family) adj1 (practice$ or practitioner$)).ti,ab.
75. (primary care or primary healthcare or primary health care or primary health service$).ti,ab.
76. (family adj (medic$ or doctor$ or physician$ or health)).ti,ab.
77. (70 or 71) and (72 or 73 or 74 or 75 or 76)
78. 77 and 68
Medline In-Process Current Week (2009-08-17)
1. somati#ation.ti,ab.
2. somatoform.ti,ab.
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9. (non organic$ or nonorganic$).ti,ab.
10. (unexplain$ adj1 medical$).ti,ab.
11. (unexplain$ adj1 (sympt$ or problem$ or condition$ or complain$)).ti,ab.
12. ((non specific or nonspecific) adj2 (sympt$ or problem$ or condition$ or complain$)).ti,ab.
13. ((unexplain$ or inexpl$) and (health$ or medical$ or physical$) and (sympt$ or problem$ or condition$ or complain$)).ti,ab.
14. frequent$ attend$.ti,ab.
15. (high utilis$ or high utiliz$).ti,ab.
16. or/1-15
17. (functional somatic adj2 (sympt$ or syndr$)).ti,ab.
18. fibromyalgi$.ti,ab.
19. chronic widespread pain.ti,ab.
20. fatigue syndrome.ti,ab.
21. ((non cardiac or noncardiac or non specific or nonspecific) adj2 chest pain).ti,ab.
22. NCCP.ti,ab.
23. (IBS or irritable bowel syndrome$).ti,ab.
24. multiple chemical sensitivity.ti,ab.
25. idiopathic environmental intolerance.ti,ab.
26. (premenstrual adj2 (syndrome$ or tension$)).ti,ab.
27. ((non ulcer nonulcer or functional) adj2 dyspepsia).ti,ab.
28. cumulative trauma disorder$.ti,ab.
29. repe$ strain injur$.ti,ab.
30. ((tension type or idiopathic or psychogenic) adj2 headache$).ti,ab.

















48. (clinic$ adj3 (trial$ or study or studies$)).ti,ab.
49. ((singl$ or doubl$ or tripl$) adj (blind$ or mask$ or dummy)).ti,ab.
50. (control$ or prospectiv$ or volunteer$).ti,ab.
51. or/44-50
52. 51 and 43 and (32 or 16)
Search terms for Consultation-Liaison Psychiatry and Primary Care:
53. (consultation liaison adj2 psychiatr$).ti,ab.
54. C-L psychiatr$.ti,ab.
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55. ((general or family) adj1 (practice$ or practitioner$)).ti,ab.
56. ((primary adj2 care) or primary healthcare or primary health care or primary health service$).ti,ab.
57. (family adj (medic$ or doctor$ or physician$ or health)).ti,ab.
58. (53 or 54) and (55 or 56 or 57)
Cochrane’s CENTRAL Register of Controlled Trials (Issue 2, 2009) was searched as follows:
#1. exp SOMATOFORM DISORDERS/
(somatoform disorders/ or conversion disorder/ or hypochondriasis/ or neurasthenia/)
#2. PSYCHOPHYSIOLOGIC DISORDERS/
#3. PSYCHOSOMATIC MEDICINE/








#12. (non NEAR/2 organic*) or nonorganic*
#13. unexplain* NEAR/2 (medical* or sympt* or problem* or condition* or complain*)
#14. (non NEAR/2 specific) NEAR/2 (sympt* or problem* or condition* or complain*)
#15. (nonspecific) NEAR/2 (sympt* or problem* or condition* or complain*)
#16. ((unexplain* or inexpl*) and (health* or medical* or physical*) and (sympt* or problem* or condition* or complain*))
#17. frequent* NEAR/2 attend*
#18. (high NEAR/2 utilis*) or (high NEAR/2 utiliz*)
#19. (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18)
#20. (functional NEXT somatic) NEAR sympt*
#21. (functional NEXT somatic) NEAR syndr*
#22. FIBROMYALGIA/
#23. fibromyalgia*
#24. chronic NEAR widespread NEAR pain
#25. FATIGUE SYNDROME, CHRONIC/
#26. fatigue NEAR/2 syndrome
#27. (non NEXT cardiac) NEAR (chest NEXT pain)
#28. noncardiac NEAR (chest NEXT pain)
#29. (non NEXT specific) NEAR (chest NEXT pain)
#30. nonspecific NEAR (chest NEXT pain)
#31. NCCP.
#32. IRRITABLE BOWEL SYNDROME/
#33. irritable NEXT bowel NEXT syndrome*
#34. IBS
#35. MULTIPLE CHEMICAL SENSITIVITY/
#36. multiple NEXT chemical NEXT sensitivity
#37. idiopathic NEXT environmental NEXT intolerance
#38. PREMENSTRUAL SYNDROME/
#39. premenstrual NEAR (syndrome* or tension*)
#40. (non NEXT ulcer) NEAR dyspepsia
#41. (nonulcer or functional) NEAR dyspepsia
#42. CUMULATIVE TRAUMA DISORDERS/
(cumulative trauma disorders/ or carpal tunnel syndrome/ or ulnar nerve compression syndromes/ or cubital tunnel syndrome/)
#43. cumulative NEXT trauma NEXT disorder*
#44. repe* NEXT strain NEXT injur*
#45. (tension NEXT type) NEAR headache
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#46. (idiopathic or psychogenic) NEAR headache*
#47. exp TEMPOROMANDIBULAR JOINT DISORDERS/
(temporomandibular joint disorders/ or temporomandibular joint dysfunction syndrome/)
#48. TMJ NEAR (disease* or disorder* or dysfunction*)
#49. (temporomandibular NEXT joint) NEAR (disease* or disorder* or dysfunction*)
#50. (#19 or #20 or #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30 or #31 or #32 or #33 or #34 or #35 or #36 or
#37 or #38 or #39 or #40 or #41 or #42 or #43 or #44 or #45 or #46 or #47 or #48# or #49)
#51. #50 or 19.
#52. INTERDISCIPLINARY COMMUNICATION/
#53. interdisciplinary NEXT communication
#54. multidisciplinary NEXT communication
#55. exp CORRESPONDENCE AS TOPIC/
correspondence as topic/ or electronic mail/
#56. (correspondence or letter*):ti,ab
#57. exp “REFERRAL AND CONSULTATION”/
(“referral and consultation”/ or ethics consultation/ or gatekeeping/ or physician self-referral/ or remote consultation/)
#58. (recommendation or referral or consultation)
#59. CASE MANAGEMENT/
#60. case NEXT management
#61. liaison
#62. psychiatri* NEXT consult*
#63. collaborative NEXT intervention*
#64. specialist NEXT consultation*
#65. (#52 or #53 or #54 or #55 or #56 or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64)
66. #65 and #51
OVID EMBASE was searched as follows:
1. Somatoform Disorder/
(somatoform disorder/ or body dysmorphic disorder/ or cardiac anxiety/ or conversion disorder/ or delusional pregnancy/ or hypochondriasis/ or











12. (non organic$ or nonorganic$).ti,ab.
13. (unexplain$ adj1 medical$).ti,ab.
14. (unexplain$ adj1 (sympt$ or problem$ or condition$ or complain$)).ti,ab.
15 ((non specific or nonspecific) adj2 (sympt$ or problem$ or condition$ or complain$)).ti,ab.
16. ((unexplain$ or inexpl$) and (health$ or medical$ or physical$) and (sympt$ or problem$ or condition$ or complain$)).ti,ab.
17. frequent$ attend$.ti,ab.
18. (high utilis$ or high utiliz$).ti,ab.
19. or/1-18
20. (functional somatic adj2 (sympt$ or syndr$)).ti,ab.
21. Fibromyalgia/
22. fibromyalgi$.ti,ab.
23. chronic widespread pain.ti,ab.
24. Fatigue Syndrome, Chronic/
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25. fatigue syndrome.ti,ab.
26. ((non cardiac or noncardiac or non specific or nonspecific) adj2 chest pain).ti,ab.
27. NCCP.ti,ab.
28. Irritable Colon/
29. (IBS or (irritable bowel syndrome$)).ti,ab.
30. multiple chemical sensitivity.mp.
31. idiopathic environmental intolerance.ti,ab.
32. Premenstrual Syndrome/
33. premenstrual adj2 (syndrome$ or tension$).ti,ab.
34. ((non ulcer nonulcer or functional) adj2 dyspepsia).ti,ab.
35. exp Cumulative Trauma Disorders/
(cumulative trauma disorder/ or carpal tunnel syndrome/ or iliotibial band friction syndrome/ or medial tibial stress syndrome/ or repetitive
strain injury/ or tennis elbow/ or vibration syndrome/)
36. cumulative trauma disorder$.ti,ab.
37. repe$ strain injur$.ti,ab.
38. ((tension type or idiopathic or psychogenic) adj2 headache$).ti,ab.
39. Temporomandibular Joint Disorders/
40. ((temporomandibular joint or TMJ) adj2 (disease$ or disorder$ or dysfunction$)).ti,ab.
41. or/20-40








50. ((consultation$ or specialist$ or physician$ or psychiatri$) and (letter$ or correspondence or communication$ or collaboration$




54. major clinical study.de.
55. clinical article.de.
56. clinical trial.de.
57. controlled clinical trial.de.
58. controlled study.de.
59. randomized controlled trial.de.
60. double blind procedure.de.






67. (randomi#ed or randomly).ti,ab.
68. ((singl$ or doubl$ or tripl$) adj (blind$ or mask$ or dummy)).ti,ab.
69. placebo$.tw.
70. (clinic$ adj3 (trial$ or study or studies$)).ti,ab.
71. comparative stud$.ti,ab.
72. (control$ or prospectiv$ or volunteer$).ti,ab.
73. or/54-72
74. ((animal or nonhuman) not (human and (animal or nonhuman))).de.
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75. 73 not 74
76. 75 and 53 and 42
Search terms for Consultation-Liaison Psychiatry and Primary Care:
77. Liaison psychiatry/
78. (consultation liaison adj2 psychiatr$).ti,ab.
79. C-L psychiatr$.ti,ab.
80. Primary medical care/
81. General practitioner/
82. ((general or family) adj1 (practice$ or practitioner$)).ti,ab.
83. (primary care or primary healthcare or primary health care or primary health service$).ti,ab.
84. (family adj (medic$ or doctor$ or physician$ or health)).ti,ab.
85. (77 or 78 or 79) and (80 or 81 or 82 or 83 or 84)
86. 85 and 75
OVID PsycINFO was searched as follows:
1. exp Somatoform Disorders/
(somatoform disorders/ or body dysmorphic disorder/ or exp conversion disorder/(conversion disorder/ or hysterical paralysis/ or hysterical vision










11. (non organic$ or nonorganic$).tw.
12. (unexplain$ adj1 medical$).tw.
13. (unexplain$ adj1 (sympt$ or problem$ or condition$ or complain$)).tw.
14 ((non specific or nonspecific) adj2 (sympt$ or problem$ or condition$ or complain$)).tw.
15. ((unexplain$ or inexpl$) and (health$ or medical$ or physical$) and (sympt$ or problem$ or condition$ or complain$)).tw.
16. frequent$ attend$.tw.
17. (high utilis$ or high utiliz$).tw.
18. or/1-17
19. (functional somatic adj2 (sympt$ or syndr$)).tw.
20. Fibromyalgia/
21. fibromyalgi$.tw.
22. chronic widespread pain.tw.
23. Chronic Fatigue Syndrome/
24. fatigue syndrome.tw.
25. ((non cardiac or noncardiac or non specific or nonspecific) adj2 chest pain).tw.
26. NCCP.tw.
27. Irritable Bowel Syndrome/
28. (IBS or irritable bowel syndrome$).tw.
29. multiple chemical sensitivity.tw.
30. idiopathic environmental intolerance.tw.
31. Premenstrual Syndrome/
32. premenstrual adj2 (syndrome$ or tension$).tw.
33. ((non ulcer or nonulcer or functional) adj2 dyspepsia).tw.
34. cumulative trauma disorder$.tw.
35. repe$ strain injur$.tw.
36. ((tension type or idiopathic or psychogenic) adj2 headache$).tw.
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37. Musculoskeletal disorders/
38. ((temporomandibular joint or TMJ) adj2 (disease$ or disorder$ or dysfunction$)).tw.
39. or/19-38
40. 19 or 39
41. Interdisciplinary treatment approach/





47. (recommendation or referral or consultation).tw.
48. ((consultation$ or specialist$ or physician$ or psychiatri$) aand (letter$ or correspondence or communication$ or collaboration$






54. Interdisciplinary Treatment Approach/
55. exp Professional consultation
(professional consultation or consultation liaison psychiatry/)
56. or/41-55











68. (clinical adj3 trial$).tw.
69. (research adj3 design).tw.
70. (evaluat$ adj3 stud$).tw.
71. (prospectiv$ adj3 stud$).tw.
72. ((singl$ or doubl$ or tripl$) adj3 (blind$ or mask$ or dummy)).tw.
73. or/8-22
74. (animal NOT (animal and (human or inpatient or outpatient))).po.
75. 73 not 74
76. 75 and 56 and 40
Search terms for Consultation-Liaison Psychiatry and Primary Care:
77. Consultation liaison psychiatry/
78. (consultation liaison adj2 psychiatr$).tw.
79. C-L psychiatr$.ti,ab.
80. Primary health care/
81. General practitioners/
82. Family physicians/
83. ((general or family) adj1 (practice$ or practitioner$)).ti,ab.
84. (primary care or primary healthcare or primary health care or primary health service$).ti,ab.
85. (family adj (medic$ or doctor$ or physician$ or health)).ti,ab.
86. (77 or 78 or 79) and (80 or 81 or 82 or 83 or 84 or 85)
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87. 86 and 75
Appendix 2. CCDAN-CTR Search Strategies
The CCDAN-CTR References Register was searched using the following terms:
Free Text = (“medically unexplained” or “unexplained medical*” or ”unexplained symptom*“ or “unexplained physical” or MUS or
MUPS or ”frequent attend*“ or ”high utili*“ or ”high-utili*“ or psychosomatic* or somatisation or somatization or somatoform or
hypochondriasis or neurathen* or “conversion disorder*” or psychophysiologic* or psychosomat* or psychogen* or “non organic*”
or non-organic*” or “nonorganic*” or “functional somatic*” or fibromyalgia* or “chronic widespread pain” or “fatigue syndrome” or
((“non cardiac” or non-cardiac or noncardiac or “non specific” or “non-specific” or nonspecific) and “chest pain”) or NCCP or IBS or
“irritable bowel syndrome*” or “multiple chemical sensitivit*” or “idiopathic environmental intolerance*” or “premenstrual syndrome”
or “premenstrual tension” or “non ulcer dyspepsia” or non-ulcer dyspepsia” or “nonulcer dyspepsia” or “functional dyspepsia” or
“cumulative traumadisorder*” or “repe* strain injur*” or “tension type headache*” or “tension-type headache*” or “idiopathic headache*”
or “psychogenic headache*” or “temoromandibular joint disorder*” or TMJ or ((“non specific” or “non-specific” on nonspecific or
unexplain* or inexpl*) and ( symp* or problem* or complain* or condition*)) AND
Free Text = (”psychiatric consultation*“ or ”collaborative intervention*“ or ”specialist consultation*“ or ”case management“ or liaison or
correspondence or letter* or referral* or ”interdisciplinary communication“ or ”multidisciplinary communication“ or recommendation*
or consultation*)
The CCDAN-CTR Studies Register was searched using the terms:
consultation” or “collaborative intervention” or “case management” or liaison or correspondence or letter or referral or communication)
AND
“medically unexplained” or somatoform or somatization or psychosomatic or somatic or “frequent attend*” or “high utili*” or “con-
version disorder” or neurasthenia or fibromyalgia or “fatigue syndrome” or “chronic fatigue“ or hypochondriasis or “premenstrual
dysphoric disorder” or “premenstrual syndrome” or “premenstrual symptoms” or “irritable bowel syndrome” or IBS”
C O N T R I B U T I O N S O F A U T H O R S
- R. Hoedeman: designing and writing the concept of the protocol and review, screening and selecting the papers, extracting the data,
assessing the quality of the studies, entering the data into RevMan, interpreting the data, securing funding for the review.
- A.H. Blankenstein: co-author of the protocol and review, screening and selecting the papers, extracting the data, assessing the quality
of the studies, interpreting the data.
- C.M. van der Feltz-Cornelis: general advice on the review, third reviewer assessing eligibility for inclusion and quality assessment of
the studies.
- B. Krol: general advice on the review, providing methodological advice on the interpretation of the data
- R.E. Stewart: extraction of the data, configuring and presenting the data, providing statistical support
- J.J.W. Groothoff: responsible for the scientific quality of the review
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D E C L A R A T I O N S O F I N T E R E S T
C.M. van der Feltz-Cornelis is first author of one of the included studies. She did not participate in the quality assessment of her own
study. She had a limited role in the quality assessment of the other studies, for which the final assessment and final decisions were all
taken by the first two authors.
S O U R C E S O F S U P P O R T
Internal sources
• ArboNed Utrecht, Netherlands.
• University Medical Center Groningen, University of Groningen (UMCG), Netherlands.
• VU University Medical Centre, Amsterdam, Netherlands.
External sources
• Dutch Ministry of Social Affairs and Employment provided a grant as part of the Knowledge Infrastructure in OHS program,
Netherlands.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We performed the protocol as described. We sub-divided medical consumption into medical outpatient care and medical inpatient
care since, due to the nature of the intervention, the effects on outpatient care and inpatient care were expected to be different. We
added perceived health as a secondary outcome. This outcome is included in measurement instruments to assess functioning (especially
RAND and SF-36), but also measures other aspects than physical and mental (role) functioning. To make this distinction we added
this outcome.
In this review we assessed the methodological quality according to The Cochrane Collaboration’s Risk of Bias tool (Higgins 2008a) and
not with the Tulder checklist (Van Tulder 1997; Van Tulder 2003) as indicated in our protocol. This was done on advice of the peer
reviewers, to enhance the comparability of the review. We extended the checklist with three criteria: assessing MUPS with validated
instruments; complete description of baseline characteristics and acceptable pre-randomization dropout.
We also added some references with regard to what is known about the relationship between MUPS and sickness absence.
I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Interview, Psychological; ∗Medical Records; Anxiety [diagnosis; psychology]; Case Management [organization & administration];
Cross-Over Studies; Depression [diagnosis; psychology]; Health Services Needs and Demand [economics; statistics & numerical
data]; Patient-Centered Care; Primary Health Care; Psychiatry; Randomized Controlled Trials as Topic; Referral and Consultation
[∗organization & administration]; Somatoform Disorders [∗diagnosis; economics; psychology; ∗therapy]
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MeSH check words
Humans
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